ONTOLOGY REPORT - ANNOTATIONS
| Term: | 17beta-estradiol |
|
| Accession: | CHEBI:16469
|
browse the term
|
| Definition: | The 17beta-isomer of estradiol. |
| Synonyms: | exact_synonym: | estra-1,3,5(10)-triene-3,17beta-diol |
| | related_synonym: | 17beta-estra-1,3,5(10)-triene-3,17-diol; 17beta-oestradiol; C18H24O2; Estradiol; InChI=1S/C18H24O2/c1-18-9-8-14-13-5-3-12(19)10-11(13)2-4-15(14)16(18)6-7-17(18)20/h3,5,10,14-17,19-20H,2,4,6-9H2,1H3/t14-,15-,16+,17+,18+/m1/s1; InChIKey=VOXZDWNPVJITMN-ZBRFXRBCSA-N; [H][C@]12CC[C@]3(C)[C@@H](O)CC[C@@]3([H])[C@]1([H])CCc1cc(O)ccc21; beta-Estradiol; cis-estradiol |
| | alt_id: | CHEBI:14219; CHEBI:23963; CHEBI:42475; CHEBI:4864 |
| | xref_casrn: | 50-28-2 |
| | xref: | Beilstein:1914275 "Beilstein Registry Number"; ChEMBL:127626 "ChEMBL COMPOUND"; ChemIDplus:50-28-2 "CAS Registry Number"; CiteXplore:10438974 "PubMed citation"; CiteXplore:3621671 "PubMed citation"; DrugBank:DB00783 "DrugBank"; Gmelin:290805 "Gmelin Registry Number"; KEGG COMPOUND:50-28-2 "CAS Registry Number"; KEGG COMPOUND:C00951 "KEGG COMPOUND"; LIPID MAPS:LMST02010001 "LIPID MAPS instance" |
| | xref_mesh: | MESH:D004958 |
| | xref: | NIST Chemistry WebBook:50-28-2 "CAS Registry Number"; PDBeChem:EST "PDBeChem"; Wikipedia:Estradiol "Wikipedia" |
|
|
17beta-estradiol
|
| G |
2610018G03Rik |
RIKEN cDNA 2610018G03 gene |
|
increases expression |
ISO |
X |
48,194,613 |
48,245,033 |
RGD:6480464 |
CTD |
| G |
2810417H13Rik |
RIKEN cDNA 2810417H13 gene |
|
increases expression |
ISO |
9 |
65,738,130 |
65,751,358 |
RGD:6480464 |
CTD |
| G |
5330417C22Rik |
RIKEN cDNA 5330417C22 gene |
|
multiple interactions |
ISO |
3 |
108,260,987 |
108,339,440 |
RGD:6480464 |
CTD |
| G |
5330417C22Rik |
RIKEN cDNA 5330417C22 gene |
|
increases expression |
ISO |
3 |
108,260,987 |
108,339,440 |
RGD:6480464 |
CTD |
| G |
Abcc8 |
ATP-binding cassette, sub-family C (CFTR/MRP), member 8 |
|
multiple interactions |
ISO |
7 |
53,359,893 |
53,435,403 |
RGD:6480464 |
CTD |
| G |
Abcc8 |
ATP-binding cassette, sub-family C (CFTR/MRP), member 8 |
|
affects response to substance |
EXP |
7 |
53,359,893 |
53,435,403 |
RGD:6480464 |
CTD |
| G |
Abcc8 |
ATP-binding cassette, sub-family C (CFTR/MRP), member 8 |
|
decreases response to substance |
ISO |
7 |
53,359,893 |
53,435,403 |
RGD:6480464 |
CTD |
| G |
Abcc8 |
ATP-binding cassette, sub-family C (CFTR/MRP), member 8 |
|
multiple interactions |
EXP |
7 |
53,359,893 |
53,435,403 |
RGD:6480464 |
CTD |
| G |
Abcc8 |
ATP-binding cassette, sub-family C (CFTR/MRP), member 8 |
|
increases response to substance |
ISO |
7 |
53,359,893 |
53,435,403 |
RGD:6480464 |
CTD |
| G |
Abcc8 |
ATP-binding cassette, sub-family C (CFTR/MRP), member 8 |
|
affects binding |
ISO |
7 |
53,359,893 |
53,435,403 |
RGD:6480464 |
CTD |
| G |
Abcc9 |
ATP-binding cassette, sub-family C (CFTR/MRP), member 9 |
|
affects binding |
EXP |
6 |
142,536,382 |
142,650,794 |
RGD:6480464 |
CTD |
| G |
Abcc9 |
ATP-binding cassette, sub-family C (CFTR/MRP), member 9 |
|
multiple interactions |
EXP |
6 |
142,536,382 |
142,650,794 |
RGD:6480464 |
CTD |
| G |
Ahr |
aryl-hydrocarbon receptor |
|
decreases expression |
ISO |
12 |
36,182,651 |
36,219,661 |
RGD:6480464 |
CTD |
| G |
AI314180 |
expressed sequence AI314180 |
|
affects expression |
ISO |
4 |
58,812,902 |
58,925,597 |
RGD:6480464 |
CTD |
| G |
Alppl2 |
alkaline phosphatase, placental-like 2 |
|
increases expression |
ISO |
1 |
88,983,265 |
88,986,503 |
RGD:6480464 |
CTD |
| G |
Alppl2 |
alkaline phosphatase, placental-like 2 |
|
multiple interactions |
ISO |
1 |
88,983,265 |
88,986,503 |
RGD:6480464 |
CTD |
| G |
Anln |
anillin, actin binding protein |
|
increases expression |
ISO |
9 |
22,135,658 |
22,193,650 |
RGD:6480464 |
CTD |
| G |
Ap3d1 |
adaptor-related protein complex 3, delta 1 subunit |
|
decreases expression |
EXP |
10 |
80,169,723 |
80,204,956 |
RGD:6480464 |
CTD |
| G |
Apobec3 |
apolipoprotein B mRNA editing enzyme, catalytic polypeptide 3 |
|
increases expression |
ISO |
15 |
79,722,838 |
79,738,859 |
RGD:6480464 |
CTD |
| G |
Arap3 |
ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 3 |
|
multiple interactions |
ISO |
18 |
38,132,277 |
38,157,228 |
RGD:6480464 |
CTD |
| G |
Arpc4 |
actin related protein 2/3 complex, subunit 4 |
|
increases expression |
ISO |
6 |
113,328,107 |
113,340,441 |
RGD:6480464 |
CTD |
| G |
Aspm |
asp (abnormal spindle)-like, microcephaly associated (Drosophila) |
|
increases expression |
ISO |
1 |
141,351,350 |
141,390,665 |
RGD:6480464 |
CTD |
| G |
Atad2 |
ATPase family, AAA domain containing 2 |
|
increases expression |
ISO |
15 |
57,925,602 |
57,966,637 |
RGD:6480464 |
CTD |
| G |
Atp5o |
ATP synthase, H+ transporting, mitochondrial F1 complex, O subunit |
|
affects binding |
ISO |
16 |
91,925,468 |
91,931,875 |
RGD:6480464 |
CTD |
| G |
Aurkb |
aurora kinase B |
|
increases expression |
ISO |
11 |
68,859,145 |
68,865,164 |
RGD:6480464 |
CTD |
| G |
Auts2 |
autism susceptibility candidate 2 |
|
decreases expression |
ISO |
5 |
131,913,552 |
133,018,213 |
RGD:6480464 |
CTD |
| G |
Bglap3 |
bone gamma-carboxyglutamate protein 3 |
|
increases expression |
ISO |
3 |
88,172,539 |
88,173,642 |
RGD:6480464 |
CTD |
| G |
Bglap3 |
bone gamma-carboxyglutamate protein 3 |
|
multiple interactions |
ISO |
3 |
88,172,539 |
88,173,642 |
RGD:6480464 |
CTD |
| G |
Bglap3 |
bone gamma-carboxyglutamate protein 3 |
|
multiple interactions |
ISO |
3 |
88,172,539 |
88,173,642 |
RGD:6480464 |
CTD |
| G |
Bglap3 |
bone gamma-carboxyglutamate protein 3 |
|
decreases expression |
ISO |
3 |
88,172,539 |
88,173,642 |
RGD:6480464 |
CTD |
| G |
Bglap3 |
bone gamma-carboxyglutamate protein 3 |
|
increases expression |
ISO |
3 |
88,172,539 |
88,173,642 |
RGD:6480464 |
CTD |
| G |
Birc5 |
baculoviral IAP repeat-containing 5 |
|
increases expression |
ISO |
11 |
117,710,551 |
117,717,057 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
increases activity |
ISO |
8 |
47,702,803 |
47,724,071 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
ISO |
8 |
47,702,803 |
47,724,071 |
RGD:6480464 |
CTD |
| G |
Casp8 |
caspase 8 |
|
multiple interactions |
ISO |
1 |
58,852,218 |
58,904,347 |
RGD:6480464 |
CTD |
| G |
Casp8 |
caspase 8 |
|
increases activity |
ISO |
1 |
58,852,218 |
58,904,347 |
RGD:6480464 |
CTD |
| G |
Casp9 |
caspase 9 |
|
increases activity |
ISO |
4 |
141,349,527 |
141,371,890 |
RGD:6480464 |
CTD |
| G |
Casp9 |
caspase 9 |
|
multiple interactions |
ISO |
4 |
141,349,527 |
141,371,890 |
RGD:6480464 |
CTD |
| G |
Ccdc170 |
coiled-coil domain containing 170 |
|
decreases expression |
ISO |
10 |
5,785,430 |
5,836,669 |
RGD:6480464 |
CTD |
| G |
Ccna2 |
cyclin A2 |
|
increases expression |
ISO |
3 |
36,463,787 |
36,470,918 |
RGD:6480464 |
CTD |
| G |
Ccnd1 |
cyclin D1 |
|
increases expression |
ISO |
7 |
152,115,836 |
152,125,830 |
RGD:6480464 |
CTD |
| G |
Cdc23 |
CDC23 cell division cycle 23 |
|
increases expression |
ISO |
18 |
34,791,337 |
34,811,390 |
RGD:6480464 |
CTD |
| G |
Cdc6 |
cell division cycle 6 |
|
increases expression |
ISO |
11 |
98,769,203 |
98,785,256 |
RGD:6480464 |
CTD |
| G |
Cdk1 |
cyclin-dependent kinase 1 |
|
increases expression |
ISO |
10 |
68,799,383 |
68,815,660 |
RGD:6480464 |
CTD |
| G |
Cdt1 |
chromatin licensing and DNA replication factor 1 |
|
increases expression |
ISO |
8 |
125,091,915 |
125,097,030 |
RGD:6480464 |
CTD |
| G |
Cenpk |
centromere protein K |
|
increases expression |
ISO |
13 |
105,019,035 |
105,039,697 |
RGD:6480464 |
CTD |
| G |
Cga |
glycoprotein hormones, alpha subunit |
|
multiple interactions |
ISO |
4 |
34,841,028 |
34,854,623 |
RGD:6480464 |
CTD |
| G |
Cga |
glycoprotein hormones, alpha subunit |
|
decreases expression |
ISO |
4 |
34,841,028 |
34,854,623 |
RGD:6480464 |
CTD |
| G |
Ctsd |
cathepsin D |
|
increases secretion |
ISO |
7 |
149,561,821 |
149,573,775 |
RGD:6480464 |
CTD |
| G |
Ctsd |
cathepsin D |
|
multiple interactions |
ISO |
7 |
149,561,821 |
149,573,775 |
RGD:6480464 |
CTD |
| G |
Ctsd |
cathepsin D |
|
multiple interactions |
ISO |
7 |
149,561,821 |
149,573,775 |
RGD:6480464 |
CTD |
| G |
Ctsd |
cathepsin D |
|
multiple interactions |
ISO |
7 |
149,561,821 |
149,573,775 |
RGD:6480464 |
CTD |
| G |
Ctsd |
cathepsin D |
|
increases expression |
ISO |
7 |
149,561,821 |
149,573,775 |
RGD:6480464 |
CTD |
| G |
Ctsd |
cathepsin D |
|
increases expression |
ISO |
7 |
149,561,821 |
149,573,775 |
RGD:6480464 |
CTD |
| G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
multiple interactions |
ISO |
9 |
57,535,735 |
57,551,629 |
RGD:6480464 |
CTD |
| G |
Cyp2c55 |
cytochrome P450, family 2, subfamily c, polypeptide 55 |
|
increases expression |
ISO |
19 |
39,081,509 |
39,117,177 |
RGD:6480464 |
CTD |
| G |
Cyp2c65 |
cytochrome P450, family 2, subfamily c, polypeptide 65 |
|
increases chemical synthesis |
ISO |
19 |
39,135,496 |
39,168,438 |
RGD:6480464 |
CTD |
| G |
Cyp4f18 |
cytochrome P450, family 4, subfamily f, polypeptide 18 |
|
decreases expression |
ISO |
8 |
74,512,381 |
74,533,525 |
RGD:6480464 |
CTD |
| G |
D130003B22Rik |
RIKEN cDNA D130003B22 gene |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
D130003B22Rik |
RIKEN cDNA D130003B22 gene |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Dlgap5 |
discs, large (Drosophila) homolog-associated protein 5 |
|
increases expression |
ISO |
14 |
48,007,454 |
48,038,082 |
RGD:6480464 |
CTD |
| G |
Dohh |
deoxyhypusine hydroxylase/monooxygenase |
|
increases expression |
ISO |
10 |
80,847,173 |
80,851,097 |
RGD:6480464 |
CTD |
| G |
Espl1 |
extra spindle poles-like 1 (S. cerevisiae) |
|
increases expression |
ISO |
15 |
102,126,724 |
102,154,787 |
RGD:6480464 |
CTD |
| G |
Esr1 |
estrogen receptor 1 (alpha) |
|
decreases expression |
ISO |
10 |
5,342,780 |
5,734,495 |
RGD:6480464 |
CTD |
| G |
Esr1 |
estrogen receptor 1 (alpha) |
|
multiple interactions |
ISO |
10 |
5,342,780 |
5,734,495 |
RGD:6480464 |
CTD |
| G |
Esr1 |
estrogen receptor 1 (alpha) |
|
decreases expression |
ISO |
10 |
5,342,780 |
5,734,495 |
RGD:6480464 |
CTD |
| G |
Esr1 |
estrogen receptor 1 (alpha) |
|
multiple interactions |
ISO |
10 |
5,342,780 |
5,734,495 |
RGD:6480464 |
CTD |
| G |
Esr1 |
estrogen receptor 1 (alpha) |
|
multiple interactions |
ISO |
10 |
5,342,780 |
5,734,495 |
RGD:6480464 |
CTD |
| G |
Esr1 |
estrogen receptor 1 (alpha) |
|
multiple interactions |
EXP |
10 |
5,342,780 |
5,734,495 |
RGD:6480464 |
CTD |
| G |
Esr1 |
estrogen receptor 1 (alpha) |
|
multiple interactions |
EXP |
10 |
5,342,780 |
5,734,495 |
RGD:6480464 |
CTD |
| G |
Esr1 |
estrogen receptor 1 (alpha) |
|
multiple interactions |
EXP |
10 |
5,342,780 |
5,734,495 |
RGD:6480464 |
CTD |
| G |
Esr1 |
estrogen receptor 1 (alpha) |
|
multiple interactions |
EXP |
10 |
5,342,780 |
5,734,495 |
RGD:6480464 |
CTD |
| G |
Esr1 |
estrogen receptor 1 (alpha) |
|
multiple interactions |
EXP |
10 |
5,342,780 |
5,734,495 |
RGD:6480464 |
CTD |
| G |
Esr1 |
estrogen receptor 1 (alpha) |
|
multiple interactions |
EXP |
10 |
5,342,780 |
5,734,495 |
RGD:6480464 |
CTD |
| G |
Esr1 |
estrogen receptor 1 (alpha) |
|
multiple interactions |
EXP |
10 |
5,342,780 |
5,734,495 |
RGD:6480464 |
CTD |
| G |
Esr1 |
estrogen receptor 1 (alpha) |
|
multiple interactions |
EXP |
10 |
5,342,780 |
5,734,495 |
RGD:6480464 |
CTD |
| G |
Esr1 |
estrogen receptor 1 (alpha) |
|
multiple interactions |
EXP |
10 |
5,342,780 |
5,734,495 |
RGD:6480464 |
CTD |
| G |
Esr1 |
estrogen receptor 1 (alpha) |
|
multiple interactions |
EXP |
10 |
5,342,780 |
5,734,495 |
RGD:6480464 |
CTD |
| G |
Esr1 |
estrogen receptor 1 (alpha) |
|
affects binding |
EXP |
10 |
5,342,780 |
5,734,495 |
RGD:6480464 |
CTD |
| G |
Esr1 |
estrogen receptor 1 (alpha) |
|
multiple interactions |
EXP |
10 |
5,342,780 |
5,734,495 |
RGD:6480464 |
CTD |
| G |
Esr1 |
estrogen receptor 1 (alpha) |
|
multiple interactions |
EXP |
10 |
5,342,780 |
5,734,495 |
RGD:6480464 |
CTD |
| G |
Esr1 |
estrogen receptor 1 (alpha) |
|
decreases expression |
EXP |
10 |
5,342,780 |
5,734,495 |
RGD:6480464 |
CTD |
| G |
Esr1 |
estrogen receptor 1 (alpha) |
|
increases activity |
EXP |
10 |
5,342,780 |
5,734,495 |
RGD:6480464 |
CTD |
| G |
Esr1 |
estrogen receptor 1 (alpha) |
|
decreases expression |
EXP |
10 |
5,342,780 |
5,734,495 |
RGD:6480464 |
CTD |
| G |
Esr1 |
estrogen receptor 1 (alpha) |
|
increases expression |
EXP |
10 |
5,342,780 |
5,734,495 |
RGD:6480464 |
CTD |
| G |
Esr1 |
estrogen receptor 1 (alpha) |
|
increases expression |
EXP |
10 |
5,342,780 |
5,734,495 |
RGD:6480464 |
CTD |
| G |
Esr1 |
estrogen receptor 1 (alpha) |
|
multiple interactions |
EXP |
10 |
5,342,780 |
5,734,495 |
RGD:6480464 |
CTD |
| G |
Esr1 |
estrogen receptor 1 (alpha) |
|
multiple interactions |
EXP |
10 |
5,342,780 |
5,734,495 |
RGD:6480464 |
CTD |
| G |
Esr2 |
estrogen receptor 2 (beta) |
|
increases expression |
ISO |
12 |
77,221,406 |
77,278,246 |
RGD:6480464 |
CTD |
| G |
Esr2 |
estrogen receptor 2 (beta) |
|
increases expression |
ISO |
12 |
77,221,406 |
77,278,246 |
RGD:6480464 |
CTD |
| G |
Esr2 |
estrogen receptor 2 (beta) |
|
increases localization |
ISO |
12 |
77,221,406 |
77,278,246 |
RGD:6480464 |
CTD |
| G |
Esr2 |
estrogen receptor 2 (beta) |
|
multiple interactions |
ISO |
12 |
77,221,406 |
77,278,246 |
RGD:6480464 |
CTD |
| G |
Esr2 |
estrogen receptor 2 (beta) |
|
multiple interactions |
ISO |
12 |
77,221,406 |
77,278,246 |
RGD:6480464 |
CTD |
| G |
Esr2 |
estrogen receptor 2 (beta) |
|
multiple interactions |
ISO |
12 |
77,221,406 |
77,278,246 |
RGD:6480464 |
CTD |
| G |
Esr2 |
estrogen receptor 2 (beta) |
|
multiple interactions |
ISO |
12 |
77,221,406 |
77,278,246 |
RGD:6480464 |
CTD |
| G |
Esr2 |
estrogen receptor 2 (beta) |
|
multiple interactions |
ISO |
12 |
77,221,406 |
77,278,246 |
RGD:6480464 |
CTD |
| G |
Esr2 |
estrogen receptor 2 (beta) |
|
multiple interactions |
ISO |
12 |
77,221,406 |
77,278,246 |
RGD:6480464 |
CTD |
| G |
Esr2 |
estrogen receptor 2 (beta) |
|
multiple interactions |
ISO |
12 |
77,221,406 |
77,278,246 |
RGD:6480464 |
CTD |
| G |
Esr2 |
estrogen receptor 2 (beta) |
|
multiple interactions |
ISO |
12 |
77,221,406 |
77,278,246 |
RGD:6480464 |
CTD |
| G |
Esr2 |
estrogen receptor 2 (beta) |
|
multiple interactions |
ISO |
12 |
77,221,406 |
77,278,246 |
RGD:6480464 |
CTD |
| G |
Esr2 |
estrogen receptor 2 (beta) |
|
multiple interactions |
ISO |
12 |
77,221,406 |
77,278,246 |
RGD:6480464 |
CTD |
| G |
Esr2 |
estrogen receptor 2 (beta) |
|
multiple interactions |
ISO |
12 |
77,221,406 |
77,278,246 |
RGD:6480464 |
CTD |
| G |
Esr2 |
estrogen receptor 2 (beta) |
|
multiple interactions |
EXP |
12 |
77,221,406 |
77,278,246 |
RGD:6480464 |
CTD |
| G |
Esr2 |
estrogen receptor 2 (beta) |
|
multiple interactions |
EXP |
12 |
77,221,406 |
77,278,246 |
RGD:6480464 |
CTD |
| G |
Esr2 |
estrogen receptor 2 (beta) |
|
multiple interactions |
EXP |
12 |
77,221,406 |
77,278,246 |
RGD:6480464 |
CTD |
| G |
Esr2 |
estrogen receptor 2 (beta) |
|
affects binding |
EXP |
12 |
77,221,406 |
77,278,246 |
RGD:6480464 |
CTD |
| G |
Esr2 |
estrogen receptor 2 (beta) |
|
multiple interactions |
EXP |
12 |
77,221,406 |
77,278,246 |
RGD:6480464 |
CTD |
| G |
Esr2 |
estrogen receptor 2 (beta) |
|
multiple interactions |
EXP |
12 |
77,221,406 |
77,278,246 |
RGD:6480464 |
CTD |
| G |
Esr2 |
estrogen receptor 2 (beta) |
|
multiple interactions |
EXP |
12 |
77,221,406 |
77,278,246 |
RGD:6480464 |
CTD |
| G |
Esr2 |
estrogen receptor 2 (beta) |
|
decreases expression |
EXP |
12 |
77,221,406 |
77,278,246 |
RGD:6480464 |
CTD |
| G |
Esr2 |
estrogen receptor 2 (beta) |
|
increases activity |
EXP |
12 |
77,221,406 |
77,278,246 |
RGD:6480464 |
CTD |
| G |
Esr2 |
estrogen receptor 2 (beta) |
|
increases expression |
EXP |
12 |
77,221,406 |
77,278,246 |
RGD:6480464 |
CTD |
| G |
Esr2 |
estrogen receptor 2 (beta) |
|
increases expression |
EXP |
12 |
77,221,406 |
77,278,246 |
RGD:6480464 |
CTD |
| G |
Esr2 |
estrogen receptor 2 (beta) |
|
multiple interactions |
ISO |
12 |
77,221,406 |
77,278,246 |
RGD:6480464 |
CTD |
| G |
Esr2 |
estrogen receptor 2 (beta) |
|
multiple interactions |
ISO |
12 |
77,221,406 |
77,278,246 |
RGD:6480464 |
CTD |
| G |
Esr2 |
estrogen receptor 2 (beta) |
|
affects binding |
ISO |
12 |
77,221,406 |
77,278,246 |
RGD:6480464 |
CTD |
| G |
Esr2 |
estrogen receptor 2 (beta) |
|
affects binding |
ISO |
12 |
77,221,406 |
77,278,246 |
RGD:6480464 |
CTD |
| G |
Esr2 |
estrogen receptor 2 (beta) |
|
multiple interactions |
ISO |
12 |
77,221,406 |
77,278,246 |
RGD:6480464 |
CTD |
| G |
Esr2 |
estrogen receptor 2 (beta) |
|
multiple interactions |
ISO |
12 |
77,221,406 |
77,278,246 |
RGD:6480464 |
CTD |
| G |
Esr2 |
estrogen receptor 2 (beta) |
|
decreases expression |
ISO |
12 |
77,221,406 |
77,278,246 |
RGD:6480464 |
CTD |
| G |
Fbxl19 |
F-box and leucine-rich repeat protein 19 |
|
increases expression |
ISO |
7 |
134,890,289 |
134,912,442 |
RGD:6480464 |
CTD |
| G |
Fcgbp |
Fc fragment of IgG binding protein |
|
increases expression |
EXP |
7 |
28,856,255 |
28,905,883 |
RGD:6480464 |
CTD |
| G |
Fgf13 |
fibroblast growth factor 13 |
|
multiple interactions |
ISO |
X |
56,315,327 |
56,387,613 |
RGD:6480464 |
CTD |
| G |
Fgf18 |
fibroblast growth factor 18 |
|
multiple interactions |
ISO |
11 |
33,017,430 |
33,047,400 |
RGD:6480464 |
CTD |
| G |
Fgf2 |
fibroblast growth factor 2 |
|
increases expression |
ISO |
3 |
37,247,575 |
37,303,752 |
RGD:6480464 |
CTD |
| G |
Fgf4 |
fibroblast growth factor 4 |
|
increases expression |
ISO |
7 |
152,047,291 |
152,051,148 |
RGD:6480464 |
CTD |
| G |
Fgf6 |
fibroblast growth factor 6 |
|
increases expression |
ISO |
6 |
126,965,560 |
126,974,736 |
RGD:6480464 |
CTD |
| G |
Fgf7 |
fibroblast growth factor 7 |
|
increases expression |
ISO |
2 |
125,860,394 |
125,916,921 |
RGD:6480464 |
CTD |
| G |
Fgf7 |
fibroblast growth factor 7 |
|
increases expression |
ISO |
2 |
125,860,394 |
125,916,921 |
RGD:6480464 |
CTD |
| G |
Fgf9 |
fibroblast growth factor 9 |
|
increases expression |
ISO |
14 |
58,691,523 |
58,731,557 |
RGD:6480464 |
CTD |
| G |
Fgf9 |
fibroblast growth factor 9 |
|
increases expression |
ISO |
14 |
58,691,523 |
58,731,557 |
RGD:6480464 |
CTD |
| G |
Fgf9 |
fibroblast growth factor 9 |
|
multiple interactions |
ISO |
14 |
58,691,523 |
58,731,557 |
RGD:6480464 |
CTD |
| G |
Fgfr2 |
fibroblast growth factor receptor 2 |
|
multiple interactions |
ISO |
7 |
137,305,965 |
137,410,322 |
RGD:6480464 |
CTD |
| G |
Fgfr2 |
fibroblast growth factor receptor 2 |
|
affects expression |
ISO |
7 |
137,305,965 |
137,410,322 |
RGD:6480464 |
CTD |
| G |
Fgfr2 |
fibroblast growth factor receptor 2 |
|
increases expression |
ISO |
7 |
137,305,965 |
137,410,322 |
RGD:6480464 |
CTD |
| G |
Fgfr2 |
fibroblast growth factor receptor 2 |
|
increases expression |
ISO |
7 |
137,305,965 |
137,410,322 |
RGD:6480464 |
CTD |
| G |
Fgfr2 |
fibroblast growth factor receptor 2 |
|
decreases expression |
ISO |
7 |
137,305,965 |
137,410,322 |
RGD:6480464 |
CTD |
| G |
Fgfr3 |
fibroblast growth factor receptor 3 |
|
increases expression |
ISO |
5 |
34,064,373 |
34,079,713 |
RGD:6480464 |
CTD |
| G |
Fgl2 |
fibrinogen-like protein 2 |
|
multiple interactions |
ISO |
5 |
20,878,491 |
20,884,204 |
RGD:6480464 |
CTD |
| G |
Fhl1 |
four and a half LIM domains 1 |
|
increases expression |
ISO |
X |
53,984,964 |
54,046,523 |
RGD:6480464 |
CTD |
| G |
Fhl1 |
four and a half LIM domains 1 |
|
multiple interactions |
ISO |
X |
53,984,964 |
54,046,523 |
RGD:6480464 |
CTD |
| G |
Fhl1 |
four and a half LIM domains 1 |
|
multiple interactions |
ISO |
X |
53,984,964 |
54,046,523 |
RGD:6480464 |
CTD |
| G |
Fhl1 |
four and a half LIM domains 1 |
|
decreases expression |
ISO |
X |
53,984,964 |
54,046,523 |
RGD:6480464 |
CTD |
| G |
Fhl2 |
four and a half LIM domains 2 |
|
affects expression |
ISO |
1 |
43,179,919 |
43,220,806 |
RGD:6480464 |
CTD |
| G |
Fhl2 |
four and a half LIM domains 2 |
|
multiple interactions |
ISO |
1 |
43,179,919 |
43,220,806 |
RGD:6480464 |
CTD |
| G |
Fhl2 |
four and a half LIM domains 2 |
|
multiple interactions |
ISO |
1 |
43,179,919 |
43,220,806 |
RGD:6480464 |
CTD |
| G |
Fhl2 |
four and a half LIM domains 2 |
|
increases expression |
ISO |
1 |
43,179,919 |
43,220,806 |
RGD:6480464 |
CTD |
| G |
Ficd |
FIC domain containing |
|
increases expression |
ISO |
5 |
114,185,791 |
114,190,616 |
RGD:6480464 |
CTD |
| G |
Fjx1 |
four jointed box 1 (Drosophila) |
|
multiple interactions |
ISO |
2 |
102,289,523 |
102,291,949 |
RGD:6480464 |
CTD |
| G |
Fkbp4 |
FK506 binding protein 4 |
|
increases expression |
ISO |
6 |
128,380,125 |
128,388,649 |
RGD:6480464 |
CTD |
| G |
Fkbp4 |
FK506 binding protein 4 |
|
affects expression |
ISO |
6 |
128,380,125 |
128,388,649 |
RGD:6480464 |
CTD |
| G |
Fkbp4 |
FK506 binding protein 4 |
|
affects expression |
EXP |
6 |
128,380,125 |
128,388,649 |
RGD:6480464 |
CTD |
| G |
Fkbp5 |
FK506 binding protein 5 |
|
multiple interactions |
ISO |
17 |
28,536,040 |
28,578,001 |
RGD:6480464 |
CTD |
| G |
Fkbpl |
FK506 binding protein-like |
|
multiple interactions |
ISO |
17 |
34,781,828 |
34,783,272 |
RGD:6480464 |
CTD |
| G |
Flnb |
filamin, beta |
|
decreases expression |
ISO |
14 |
8,650,471 |
8,784,102 |
RGD:6480464 |
CTD |
| G |
Flnc |
filamin C, gamma |
|
decreases expression |
ISO |
6 |
29,383,153 |
29,411,888 |
RGD:6480464 |
CTD |
| G |
Flot1 |
flotillin 1 |
|
decreases expression |
EXP |
17 |
35,960,302 |
35,969,732 |
RGD:6480464 |
CTD |
| G |
Flrt1 |
fibronectin leucine rich transmembrane protein 1 |
|
affects expression |
ISO |
19 |
7,166,491 |
7,180,219 |
RGD:6480464 |
CTD |
| G |
Flrt2 |
fibronectin leucine rich transmembrane protein 2 |
|
multiple interactions |
ISO |
12 |
96,930,436 |
97,023,425 |
RGD:6480464 |
CTD |
| G |
Flrt2 |
fibronectin leucine rich transmembrane protein 2 |
|
affects expression |
ISO |
12 |
96,930,436 |
97,023,425 |
RGD:6480464 |
CTD |
| G |
Flt1 |
FMS-like tyrosine kinase 1 |
|
decreases expression |
ISO |
5 |
148,373,772 |
148,537,564 |
RGD:6480464 |
CTD |
| G |
Fos |
FBJ osteosarcoma oncogene |
|
increases expression |
ISO |
12 |
86,814,851 |
86,818,219 |
RGD:6480464 |
CTD |
| G |
Foxm1 |
forkhead box M1 |
|
increases expression |
ISO |
6 |
128,313,012 |
128,325,904 |
RGD:6480464 |
CTD |
| G |
Fzd7 |
frizzled homolog 7 (Drosophila) |
|
affects expression |
ISO |
1 |
59,538,991 |
59,543,799 |
RGD:6480464 |
CTD |
| G |
G6pdx |
glucose-6-phosphate dehydrogenase X-linked |
|
multiple interactions |
EXP |
X |
71,654,825 |
71,674,500 |
RGD:6480464 |
CTD |
| G |
Gaa |
glucosidase, alpha, acid |
|
increases expression |
ISO |
11 |
119,129,281 |
119,147,012 |
RGD:6480464 |
CTD |
| G |
Gabbr2 |
gamma-aminobutyric acid (GABA) B receptor, 2 |
|
affects expression |
ISO |
4 |
46,676,770 |
47,004,586 |
RGD:6480464 |
CTD |
| G |
Gabbr2 |
gamma-aminobutyric acid (GABA) B receptor, 2 |
|
increases expression |
ISO |
4 |
46,676,770 |
47,004,586 |
RGD:6480464 |
CTD |
| G |
Gabbr2 |
gamma-aminobutyric acid (GABA) B receptor, 2 |
|
multiple interactions |
ISO |
4 |
46,676,770 |
47,004,586 |
RGD:6480464 |
CTD |
| G |
Gabpb2 |
GA repeat binding protein, beta 2 |
|
increases expression |
ISO |
3 |
94,985,688 |
95,021,864 |
RGD:6480464 |
CTD |
| G |
Gabra3 |
gamma-aminobutyric acid (GABA) A receptor, subunit alpha 3 |
|
increases expression |
ISO |
X |
69,678,015 |
69,901,585 |
RGD:6480464 |
CTD |
| G |
Gabra4 |
gamma-aminobutyric acid (GABA) A receptor, subunit alpha 4 |
|
affects expression |
ISO |
5 |
71,960,973 |
72,049,547 |
RGD:6480464 |
CTD |
| G |
Gabra5 |
gamma-aminobutyric acid (GABA) A receptor, subunit alpha 5 |
|
affects expression |
ISO |
7 |
64,663,039 |
64,765,379 |
RGD:6480464 |
CTD |
| G |
Gabrb3 |
gamma-aminobutyric acid (GABA) A receptor, subunit beta 3 |
|
increases expression |
ISO |
7 |
64,845,904 |
65,084,172 |
RGD:6480464 |
CTD |
| G |
Gabre |
gamma-aminobutyric acid (GABA) A receptor, subunit epsilon |
|
increases expression |
ISO |
X |
69,502,771 |
69,520,060 |
RGD:6480464 |
CTD |
| G |
Gabrp |
gamma-aminobutyric acid (GABA) A receptor, pi |
|
affects expression |
ISO |
11 |
33,450,781 |
33,478,957 |
RGD:6480464 |
CTD |
| G |
Gabrp |
gamma-aminobutyric acid (GABA) A receptor, pi |
|
increases expression |
ISO |
11 |
33,450,781 |
33,478,957 |
RGD:6480464 |
CTD |
| G |
Gad1 |
glutamate decarboxylase 1 |
|
increases expression |
ISO |
2 |
70,400,221 |
70,440,069 |
RGD:6480464 |
CTD |
| G |
Gad2 |
glutamic acid decarboxylase 2 |
|
increases expression |
ISO |
2 |
22,477,847 |
22,549,397 |
RGD:6480464 |
CTD |
| G |
Gadd45a |
growth arrest and DNA-damage-inducible 45 alpha |
|
decreases expression |
ISO |
6 |
66,985,090 |
66,987,401 |
RGD:6480464 |
CTD |
| G |
Gadd45a |
growth arrest and DNA-damage-inducible 45 alpha |
|
affects expression |
EXP |
6 |
66,985,090 |
66,987,401 |
RGD:6480464 |
CTD |
| G |
Gadd45a |
growth arrest and DNA-damage-inducible 45 alpha |
|
increases expression |
EXP |
6 |
66,985,090 |
66,987,401 |
RGD:6480464 |
CTD |
| G |
Gadd45g |
growth arrest and DNA-damage-inducible 45 gamma |
|
affects expression |
EXP |
13 |
51,942,044 |
51,943,844 |
RGD:6480464 |
CTD |
| G |
Gadd45g |
growth arrest and DNA-damage-inducible 45 gamma |
|
increases expression |
EXP |
13 |
51,942,044 |
51,943,844 |
RGD:6480464 |
CTD |
| G |
Gal |
galanin |
|
multiple interactions |
ISO |
19 |
3,409,917 |
3,414,457 |
RGD:6480464 |
CTD |
| G |
Gal |
galanin |
|
affects expression |
EXP |
19 |
3,409,917 |
3,414,457 |
RGD:6480464 |
CTD |
| G |
Gal |
galanin |
|
increases expression |
ISO |
19 |
3,409,917 |
3,414,457 |
RGD:6480464 |
CTD |
| G |
Gal |
galanin |
|
multiple interactions |
ISO |
19 |
3,409,917 |
3,414,457 |
RGD:6480464 |
CTD |
| G |
Gal |
galanin |
|
multiple interactions |
ISO |
19 |
3,409,917 |
3,414,457 |
RGD:6480464 |
CTD |
| G |
Galm |
galactose mutarotase |
|
decreases expression |
ISO |
17 |
80,526,811 |
80,584,372 |
RGD:6480464 |
CTD |
| G |
Galnt1 |
UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 1 |
|
affects expression |
ISO |
18 |
24,363,845 |
24,445,317 |
RGD:6480464 |
CTD |
| G |
Galnt1 |
UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 1 |
|
decreases expression |
ISO |
18 |
24,363,845 |
24,445,317 |
RGD:6480464 |
CTD |
| G |
Galnt12 |
UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 12 |
|
increases expression |
ISO |
4 |
47,104,825 |
47,135,914 |
RGD:6480464 |
CTD |
| G |
Galnt12 |
UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 12 |
|
multiple interactions |
ISO |
4 |
47,104,825 |
47,135,914 |
RGD:6480464 |
CTD |
| G |
Galr2 |
galanin receptor 2 |
|
multiple interactions |
ISO |
11 |
116,142,253 |
116,145,252 |
RGD:6480464 |
CTD |
| G |
Galr2 |
galanin receptor 2 |
|
increases expression |
ISO |
11 |
116,142,253 |
116,145,252 |
RGD:6480464 |
CTD |
| G |
Gap43 |
growth associated protein 43 |
|
multiple interactions |
ISO |
16 |
42,248,665 |
42,340,764 |
RGD:6480464 |
CTD |
| G |
Gars |
glycyl-tRNA synthetase |
|
increases expression |
ISO |
6 |
54,987,995 |
55,029,498 |
RGD:6480464 |
CTD |
| G |
Gas1 |
growth arrest specific 1 |
|
affects expression |
ISO |
13 |
60,275,766 |
60,278,896 |
RGD:6480464 |
CTD |
| G |
Gas2 |
growth arrest specific 2 |
|
decreases expression |
ISO |
7 |
59,134,515 |
59,249,828 |
RGD:6480464 |
CTD |
| G |
Gas6 |
growth arrest specific 6 |
|
multiple interactions |
ISO |
8 |
13,465,374 |
13,494,535 |
RGD:6480464 |
CTD |
| G |
Gas6 |
growth arrest specific 6 |
|
increases expression |
ISO |
8 |
13,465,374 |
13,494,535 |
RGD:6480464 |
CTD |
| G |
Gast |
gastrin |
|
multiple interactions |
ISO |
11 |
100,195,726 |
100,198,310 |
RGD:6480464 |
CTD |
| G |
Gatm |
glycine amidinotransferase (L-arginine:glycine amidinotransferase) |
|
decreases expression |
ISO |
2 |
122,420,209 |
122,437,013 |
RGD:6480464 |
CTD |
| G |
Gm20117 |
predicted gene, 20117 |
|
increases expression |
ISO |
15 |
79,741,604 |
79,746,338 |
RGD:6480464 |
CTD |
| G |
Gpnmb |
glycoprotein (transmembrane) nmb |
|
decreases expression |
ISO |
6 |
48,986,517 |
49,008,181 |
RGD:6480464 |
CTD |
| G |
Gpnmb |
glycoprotein (transmembrane) nmb |
|
multiple interactions |
ISO |
6 |
48,986,517 |
49,008,181 |
RGD:6480464 |
CTD |
| G |
Gpr116 |
G protein-coupled receptor 116 |
|
increases expression |
ISO |
17 |
43,526,415 |
43,596,506 |
RGD:6480464 |
CTD |
| G |
Gpr12 |
G-protein coupled receptor 12 |
|
increases expression |
ISO |
5 |
147,393,726 |
147,396,815 |
RGD:6480464 |
CTD |
| G |
Gpr126 |
G protein-coupled receptor 126 |
|
decreases expression |
ISO |
10 |
14,122,391 |
14,264,842 |
RGD:6480464 |
CTD |
| G |
Gpr126 |
G protein-coupled receptor 126 |
|
multiple interactions |
ISO |
10 |
14,122,391 |
14,264,842 |
RGD:6480464 |
CTD |
| G |
Gpr161 |
G protein-coupled receptor 161 |
|
affects expression |
ISO |
1 |
167,225,897 |
167,251,982 |
RGD:6480464 |
CTD |
| G |
Gpr17 |
G protein-coupled receptor 17 |
|
multiple interactions |
ISO |
18 |
32,102,653 |
32,109,290 |
RGD:6480464 |
CTD |
| G |
Gpr176 |
G protein-coupled receptor 176 |
|
multiple interactions |
ISO |
2 |
118,102,834 |
118,199,155 |
RGD:6480464 |
CTD |
| G |
Gpr176 |
G protein-coupled receptor 176 |
|
affects expression |
ISO |
2 |
118,102,834 |
118,199,155 |
RGD:6480464 |
CTD |
| G |
Gpr30 |
G protein-coupled receptor 30 |
|
multiple interactions |
ISO |
5 |
139,899,133 |
139,903,754 |
RGD:6480464 |
CTD |
| G |
Gpr30 |
G protein-coupled receptor 30 |
|
multiple interactions |
ISO |
5 |
139,899,133 |
139,903,754 |
RGD:6480464 |
CTD |
| G |
Gpr30 |
G protein-coupled receptor 30 |
|
multiple interactions |
ISO |
5 |
139,899,133 |
139,903,754 |
RGD:6480464 |
CTD |
| G |
Gpr30 |
G protein-coupled receptor 30 |
|
increases activity |
ISO |
5 |
139,899,133 |
139,903,754 |
RGD:6480464 |
CTD |
| G |
Gpr56 |
G protein-coupled receptor 56 |
|
affects expression |
ISO |
8 |
97,508,503 |
97,538,091 |
RGD:6480464 |
CTD |
| G |
Gpr87 |
G protein-coupled receptor 87 |
|
increases expression |
ISO |
3 |
58,982,845 |
58,984,007 |
RGD:6480464 |
CTD |
| G |
Gpr87 |
G protein-coupled receptor 87 |
|
multiple interactions |
ISO |
3 |
58,982,845 |
58,984,007 |
RGD:6480464 |
CTD |
| G |
Gprc5a |
G protein-coupled receptor, family C, group 5, member A |
|
affects expression |
ISO |
6 |
135,015,680 |
135,034,727 |
RGD:6480464 |
CTD |
| G |
Gprc5a |
G protein-coupled receptor, family C, group 5, member A |
|
increases expression |
ISO |
6 |
135,015,680 |
135,034,727 |
RGD:6480464 |
CTD |
| G |
Gprc5a |
G protein-coupled receptor, family C, group 5, member A |
|
decreases expression |
ISO |
6 |
135,015,680 |
135,034,727 |
RGD:6480464 |
CTD |
| G |
Gps2 |
G protein pathway suppressor 2 |
|
multiple interactions |
ISO |
11 |
69,727,694 |
69,730,093 |
RGD:6480464 |
CTD |
| G |
Gpt |
glutamic pyruvic transaminase, soluble |
|
decreases activity |
ISO |
15 |
76,527,194 |
76,530,105 |
RGD:6480464 |
CTD |
| G |
Gpt |
glutamic pyruvic transaminase, soluble |
|
multiple interactions |
ISO |
15 |
76,527,194 |
76,530,105 |
RGD:6480464 |
CTD |
| G |
Gpt2 |
glutamic pyruvate transaminase (alanine aminotransferase) 2 |
|
decreases expression |
ISO |
8 |
88,016,516 |
88,051,457 |
RGD:6480464 |
CTD |
| G |
Gpx2 |
glutathione peroxidase 2 |
|
multiple interactions |
ISO |
12 |
77,893,322 |
77,896,541 |
RGD:6480464 |
CTD |
| G |
Gpx2 |
glutathione peroxidase 2 |
|
decreases expression |
ISO |
12 |
77,893,322 |
77,896,541 |
RGD:6480464 |
CTD |
| G |
Gpx2 |
glutathione peroxidase 2 |
|
increases expression |
ISO |
12 |
77,893,322 |
77,896,541 |
RGD:6480464 |
CTD |
| G |
Gpx2 |
glutathione peroxidase 2 |
|
multiple interactions |
ISO |
12 |
77,893,322 |
77,896,541 |
RGD:6480464 |
CTD |
| G |
Gpx3 |
glutathione peroxidase 3 |
|
multiple interactions |
EXP |
11 |
54,716,355 |
54,723,889 |
RGD:6480464 |
CTD |
| G |
Gpx3 |
glutathione peroxidase 3 |
|
increases expression |
EXP |
11 |
54,716,355 |
54,723,889 |
RGD:6480464 |
CTD |
| G |
Gpx3 |
glutathione peroxidase 3 |
|
decreases expression |
EXP |
11 |
54,716,355 |
54,723,889 |
RGD:6480464 |
CTD |
| G |
Gramd3 |
GRAM domain containing 3 |
|
decreases expression |
ISO |
18 |
56,591,786 |
56,663,446 |
RGD:6480464 |
CTD |
| G |
Grb10 |
growth factor receptor bound protein 10 |
|
affects expression |
ISO |
11 |
11,830,502 |
11,937,423 |
RGD:6480464 |
CTD |
| G |
Grb14 |
growth factor receptor bound protein 14 |
|
multiple interactions |
ISO |
2 |
64,750,535 |
64,860,823 |
RGD:6480464 |
CTD |
| G |
Grb14 |
growth factor receptor bound protein 14 |
|
decreases expression |
ISO |
2 |
64,750,535 |
64,860,823 |
RGD:6480464 |
CTD |
| G |
Grb7 |
growth factor receptor bound protein 7 |
|
decreases expression |
ISO |
11 |
98,308,148 |
98,316,687 |
RGD:6480464 |
CTD |
| G |
Grb7 |
growth factor receptor bound protein 7 |
|
affects expression |
EXP |
11 |
98,308,148 |
98,316,687 |
RGD:6480464 |
CTD |
| G |
Greb1 |
gene regulated by estrogen in breast cancer protein |
|
increases expression |
ISO |
12 |
16,677,421 |
16,807,692 |
RGD:6480464 |
CTD |
| G |
Greb1 |
gene regulated by estrogen in breast cancer protein |
|
increases expression |
EXP |
12 |
16,677,421 |
16,807,692 |
RGD:6480464 |
CTD |
| G |
Greb1 |
gene regulated by estrogen in breast cancer protein |
|
multiple interactions |
ISO |
12 |
16,677,421 |
16,807,692 |
RGD:6480464 |
CTD |
| G |
Greb1 |
gene regulated by estrogen in breast cancer protein |
|
affects expression |
ISO |
12 |
16,677,421 |
16,807,692 |
RGD:6480464 |
CTD |
| G |
Greb1 |
gene regulated by estrogen in breast cancer protein |
|
increases expression |
ISO |
12 |
16,677,421 |
16,807,692 |
RGD:6480464 |
CTD |
| G |
Greb1 |
gene regulated by estrogen in breast cancer protein |
|
multiple interactions |
ISO |
12 |
16,677,421 |
16,807,692 |
RGD:6480464 |
CTD |
| G |
Grin2b |
glutamate receptor, ionotropic, NMDA2B (epsilon 2) |
|
increases phosphorylation |
ISO |
6 |
135,679,813 |
136,123,529 |
RGD:6480464 |
CTD |
| G |
Grin2b |
glutamate receptor, ionotropic, NMDA2B (epsilon 2) |
|
multiple interactions |
ISO |
6 |
135,679,813 |
136,123,529 |
RGD:6480464 |
CTD |
| G |
H13 |
histocompatibility 13 |
|
decreases expression |
ISO |
2 |
152,495,197 |
152,534,404 |
RGD:6480464 |
CTD |
| G |
H2-D1 |
histocompatibility 2, D region locus 1 |
|
increases expression |
ISO |
17 |
35,400,039 |
35,404,442 |
RGD:6480464 |
CTD |
| G |
H2-D1 |
histocompatibility 2, D region locus 1 |
|
multiple interactions |
ISO |
17 |
35,400,039 |
35,404,442 |
RGD:6480464 |
CTD |
| G |
H2-M3 |
histocompatibility 2, M region locus 3 |
|
increases expression |
ISO |
17 |
37,407,179 |
37,411,430 |
RGD:6480464 |
CTD |
| G |
H2-M3 |
histocompatibility 2, M region locus 3 |
|
multiple interactions |
ISO |
17 |
37,407,179 |
37,411,430 |
RGD:6480464 |
CTD |
| G |
H2-M3 |
histocompatibility 2, M region locus 3 |
|
multiple interactions |
ISO |
17 |
37,407,179 |
37,411,430 |
RGD:6480464 |
CTD |
| G |
H2-M3 |
histocompatibility 2, M region locus 3 |
|
increases expression |
ISO |
17 |
37,407,179 |
37,411,430 |
RGD:6480464 |
CTD |
| G |
H2-Q1 |
histocompatibility 2, Q region locus 1 |
|
multiple interactions |
ISO |
17 |
35,457,503 |
35,462,044 |
RGD:6480464 |
CTD |
| G |
H2-Q1 |
histocompatibility 2, Q region locus 1 |
|
increases expression |
ISO |
17 |
35,457,503 |
35,462,044 |
RGD:6480464 |
CTD |
| G |
H2-Q10 |
histocompatibility 2, Q region locus 10 |
|
multiple interactions |
ISO |
17 |
35,607,034 |
35,611,508 |
RGD:6480464 |
CTD |
| G |
H2-Q10 |
histocompatibility 2, Q region locus 10 |
|
increases expression |
ISO |
17 |
35,607,034 |
35,611,508 |
RGD:6480464 |
CTD |
| G |
Hbb-bh1 |
hemoglobin Z, beta-like embryonic chain |
|
multiple interactions |
ISO |
7 |
110,990,152 |
110,991,676 |
RGD:6480464 |
CTD |
| G |
Hibadh |
3-hydroxyisobutyrate dehydrogenase |
|
decreases expression |
ISO |
6 |
52,496,224 |
52,590,294 |
RGD:6480464 |
CTD |
| G |
Hif1a |
hypoxia inducible factor 1, alpha subunit |
|
multiple interactions |
ISO |
12 |
75,008,854 |
75,048,517 |
RGD:6480464 |
CTD |
| G |
Hif1a |
hypoxia inducible factor 1, alpha subunit |
|
increases expression |
ISO |
12 |
75,008,854 |
75,048,517 |
RGD:6480464 |
CTD |
| G |
Hist1h1c |
histone cluster 1, H1c |
|
increases expression |
ISO |
13 |
23,830,676 |
23,832,236 |
RGD:6480464 |
CTD |
| G |
Hist1h1c |
histone cluster 1, H1c |
|
multiple interactions |
ISO |
13 |
23,830,676 |
23,832,236 |
RGD:6480464 |
CTD |
| G |
Hist1h2ac |
histone cluster 1, H2ac |
|
decreases expression |
ISO |
13 |
23,773,336 |
23,775,828 |
RGD:6480464 |
CTD |
| G |
Hist1h2ae |
histone cluster 1, H2ae |
|
increases expression |
ISO |
13 |
23,662,386 |
23,663,089 |
RGD:6480464 |
CTD |
| G |
Hist1h2ag |
histone cluster 1, H2ag |
|
increases expression |
ISO |
13 |
22,134,346 |
22,134,818 |
RGD:6480464 |
CTD |
| G |
Hist1h2bh |
histone cluster 1, H2bh |
|
multiple interactions |
ISO |
13 |
23,634,841 |
23,635,221 |
RGD:6480464 |
CTD |
| G |
Hist1h2bp |
histone cluster 1, H2bp |
|
multiple interactions |
ISO |
13 |
21,879,357 |
21,881,082 |
RGD:6480464 |
CTD |
| G |
Hist2h2be |
histone cluster 2, H2be |
|
decreases expression |
ISO |
3 |
96,025,044 |
96,027,661 |
RGD:6480464 |
CTD |
| G |
Hist4h4 |
histone cluster 4, H4 |
|
increases acetylation |
ISO |
6 |
136,752,589 |
136,752,900 |
RGD:6480464 |
CTD |
| G |
Hist4h4 |
histone cluster 4, H4 |
|
multiple interactions |
ISO |
6 |
136,752,589 |
136,752,900 |
RGD:6480464 |
CTD |
| G |
Hk2 |
hexokinase 2 |
|
decreases expression |
ISO |
6 |
82,675,019 |
82,724,448 |
RGD:6480464 |
CTD |
| G |
Hkdc1 |
hexokinase domain containing 1 |
|
increases expression |
ISO |
10 |
61,845,885 |
61,885,205 |
RGD:6480464 |
CTD |
| G |
Hlf |
hepatic leukemia factor |
|
decreases expression |
ISO |
11 |
90,197,849 |
90,252,231 |
RGD:6480464 |
CTD |
| G |
Hmbs |
hydroxymethylbilane synthase |
|
affects expression |
EXP |
9 |
44,144,431 |
44,152,311 |
RGD:6480464 |
CTD |
| G |
Hmgb1 |
high mobility group box 1 |
|
increases expression |
ISO |
5 |
149,858,803 |
149,864,613 |
RGD:6480464 |
CTD |
| G |
Hmgb2 |
high mobility group box 2 |
|
increases expression |
ISO |
8 |
59,990,640 |
59,994,796 |
RGD:6480464 |
CTD |
| G |
Hmgcs2 |
3-hydroxy-3-methylglutaryl-Coenzyme A synthase 2 |
|
decreases expression |
ISO |
3 |
98,084,354 |
98,114,661 |
RGD:6480464 |
CTD |
| G |
Hmox1 |
heme oxygenase (decycling) 1 |
|
increases expression |
ISO |
8 |
77,617,517 |
77,624,492 |
RGD:6480464 |
CTD |
| G |
Hmox1 |
heme oxygenase (decycling) 1 |
|
increases expression |
ISO |
8 |
77,617,517 |
77,624,492 |
RGD:6480464 |
CTD |
| G |
Hmox1 |
heme oxygenase (decycling) 1 |
|
multiple interactions |
ISO |
8 |
77,617,517 |
77,624,492 |
RGD:6480464 |
CTD |
| G |
Hmox1 |
heme oxygenase (decycling) 1 |
|
affects expression |
EXP |
8 |
77,617,517 |
77,624,492 |
RGD:6480464 |
CTD |
| G |
Hmox1 |
heme oxygenase (decycling) 1 |
|
multiple interactions |
EXP |
8 |
77,617,517 |
77,624,492 |
RGD:6480464 |
CTD |
| G |
Hmox2 |
heme oxygenase (decycling) 2 |
|
affects expression |
ISO |
16 |
4,726,361 |
4,766,249 |
RGD:6480464 |
CTD |
| G |
Hnmt |
histamine N-methyltransferase |
|
multiple interactions |
ISO |
2 |
23,858,431 |
23,904,899 |
RGD:6480464 |
CTD |
| G |
Hnmt |
histamine N-methyltransferase |
|
increases expression |
ISO |
2 |
23,858,431 |
23,904,899 |
RGD:6480464 |
CTD |
| G |
Hnrnpa2b1 |
heterogeneous nuclear ribonucleoprotein A2/B1 |
|
increases expression |
ISO |
6 |
51,410,433 |
51,419,893 |
RGD:6480464 |
CTD |
| G |
Hnrnpa2b1 |
heterogeneous nuclear ribonucleoprotein A2/B1 |
|
affects expression |
EXP |
6 |
51,410,433 |
51,419,893 |
RGD:6480464 |
CTD |
| G |
Hnrnpd |
heterogeneous nuclear ribonucleoprotein D |
|
affects expression |
EXP |
5 |
100,384,955 |
100,407,957 |
RGD:6480464 |
CTD |
| G |
Hnrnph1 |
heterogeneous nuclear ribonucleoprotein H1 |
|
increases expression |
ISO |
11 |
50,191,221 |
50,200,030 |
RGD:6480464 |
CTD |
| G |
Hnrnpu |
heterogeneous nuclear ribonucleoprotein U |
|
increases expression |
ISO |
1 |
180,258,431 |
180,267,915 |
RGD:6480464 |
CTD |
| G |
Hnrpdl |
heterogeneous nuclear ribonucleoprotein D-like |
|
affects expression |
EXP |
5 |
100,462,596 |
100,468,241 |
RGD:6480464 |
CTD |
| G |
Homer1 |
homer homolog 1 (Drosophila) |
|
decreases expression |
ISO |
13 |
94,074,450 |
94,174,917 |
RGD:6480464 |
CTD |
| G |
Hook3 |
hook homolog 3 (Drosophila) |
|
decreases expression |
ISO |
8 |
27,131,893 |
27,229,696 |
RGD:6480464 |
CTD |
| G |
Hopx |
HOP homeobox |
|
multiple interactions |
ISO |
5 |
77,516,011 |
77,544,148 |
RGD:6480464 |
CTD |
| G |
Hoxa10 |
homeobox A10 |
|
increases expression |
ISO |
6 |
52,181,196 |
52,190,853 |
RGD:6480464 |
CTD |
| G |
Hoxa10 |
homeobox A10 |
|
multiple interactions |
ISO |
6 |
52,181,196 |
52,190,853 |
RGD:6480464 |
CTD |
| G |
Hoxa11 |
homeobox A11 |
|
multiple interactions |
ISO |
6 |
52,192,105 |
52,195,766 |
RGD:6480464 |
CTD |
| G |
Hras1 |
Harvey rat sarcoma virus oncogene 1 |
|
affects expression |
ISO |
7 |
148,375,833 |
148,379,903 |
RGD:6480464 |
CTD |
| G |
Hspb8 |
heat shock protein 8 |
|
increases expression |
ISO |
5 |
116,858,504 |
116,872,873 |
RGD:6480464 |
CTD |
| G |
Hspe1 |
heat shock protein 1 (chaperonin 10) |
|
affects expression |
EXP |
1 |
55,144,992 |
55,148,161 |
RGD:6480464 |
CTD |
| G |
Hspe1 |
heat shock protein 1 (chaperonin 10) |
|
increases expression |
ISO |
1 |
55,144,992 |
55,148,161 |
RGD:6480464 |
CTD |
| G |
Htr2c |
5-hydroxytryptamine (serotonin) receptor 2C |
|
affects expression |
ISO |
X |
143,397,056 |
143,631,820 |
RGD:6480464 |
CTD |
| G |
Htr2c |
5-hydroxytryptamine (serotonin) receptor 2C |
|
multiple interactions |
ISO |
X |
143,397,056 |
143,631,820 |
RGD:6480464 |
CTD |
| G |
Htr2c |
5-hydroxytryptamine (serotonin) receptor 2C |
|
increases expression |
ISO |
X |
143,397,056 |
143,631,820 |
RGD:6480464 |
CTD |
| G |
Ibsp |
integrin binding sialoprotein |
|
increases expression |
EXP |
5 |
104,728,306 |
104,740,491 |
RGD:6480464 |
CTD |
| G |
Icam1 |
intercellular adhesion molecule 1 |
|
increases expression |
ISO |
9 |
20,820,404 |
20,833,241 |
RGD:6480464 |
CTD |
| G |
Id1 |
inhibitor of DNA binding 1 |
|
multiple interactions |
ISO |
2 |
152,562,010 |
152,563,146 |
RGD:6480464 |
CTD |
| G |
Id1 |
inhibitor of DNA binding 1 |
|
increases expression |
ISO |
2 |
152,562,010 |
152,563,146 |
RGD:6480464 |
CTD |
| G |
Id1 |
inhibitor of DNA binding 1 |
|
affects expression |
EXP |
2 |
152,562,010 |
152,563,146 |
RGD:6480464 |
CTD |
| G |
Id1 |
inhibitor of DNA binding 1 |
|
multiple interactions |
ISO |
2 |
152,562,010 |
152,563,146 |
RGD:6480464 |
CTD |
| G |
Id2 |
inhibitor of DNA binding 2 |
|
decreases expression |
ISO |
12 |
25,778,664 |
25,780,957 |
RGD:6480464 |
CTD |
| G |
Id3 |
inhibitor of DNA binding 3 |
|
decreases expression |
ISO |
4 |
135,699,737 |
135,701,307 |
RGD:6480464 |
CTD |
| G |
Ids |
iduronate 2-sulfatase |
|
decreases expression |
ISO |
X |
67,596,244 |
67,618,260 |
RGD:6480464 |
CTD |
| G |
Ier2 |
immediate early response 2 |
|
increases expression |
ISO |
8 |
87,185,230 |
87,186,751 |
RGD:6480464 |
CTD |
| G |
Ier2 |
immediate early response 2 |
|
affects expression |
EXP |
8 |
87,185,230 |
87,186,751 |
RGD:6480464 |
CTD |
| G |
Ier3 |
immediate early response 3 |
|
affects expression |
ISO |
17 |
35,958,658 |
35,959,856 |
RGD:6480464 |
CTD |
| G |
Ier3 |
immediate early response 3 |
|
decreases expression |
ISO |
17 |
35,958,658 |
35,959,856 |
RGD:6480464 |
CTD |
| G |
Ier3 |
immediate early response 3 |
|
multiple interactions |
ISO |
17 |
35,958,658 |
35,959,856 |
RGD:6480464 |
CTD |
| G |
Ier3 |
immediate early response 3 |
|
increases expression |
ISO |
17 |
35,958,658 |
35,959,856 |
RGD:6480464 |
CTD |
| G |
Ier3 |
immediate early response 3 |
|
affects expression |
EXP |
17 |
35,958,658 |
35,959,856 |
RGD:6480464 |
CTD |
| G |
Ier3 |
immediate early response 3 |
|
increases expression |
EXP |
17 |
35,958,658 |
35,959,856 |
RGD:6480464 |
CTD |
| G |
Ifi202b |
interferon activated gene 202B |
|
increases expression |
EXP |
1 |
175,892,700 |
175,912,975 |
RGD:6480464 |
CTD |
| G |
Ifi27l1 |
interferon, alpha-inducible protein 27 like 1 |
|
multiple interactions |
ISO |
12 |
104,672,399 |
104,678,455 |
RGD:6480464 |
CTD |
| G |
Ifi27l1 |
interferon, alpha-inducible protein 27 like 1 |
|
increases expression |
ISO |
12 |
104,672,399 |
104,678,455 |
RGD:6480464 |
CTD |
| G |
Ifi44 |
interferon-induced protein 44 |
|
multiple interactions |
ISO |
3 |
151,393,886 |
151,412,923 |
RGD:6480464 |
CTD |
| G |
Ifi44 |
interferon-induced protein 44 |
|
increases expression |
ISO |
3 |
151,393,886 |
151,412,923 |
RGD:6480464 |
CTD |
| G |
Ifi44l |
interferon-induced protein 44 like |
|
increases expression |
ISO |
3 |
151,421,701 |
151,425,855 |
RGD:6480464 |
CTD |
| G |
Ifi44l |
interferon-induced protein 44 like |
|
multiple interactions |
ISO |
3 |
151,421,701 |
151,425,855 |
RGD:6480464 |
CTD |
| G |
Ifi44l |
interferon-induced protein 44 like |
|
multiple interactions |
ISO |
3 |
151,421,701 |
151,425,855 |
RGD:6480464 |
CTD |
| G |
Ifih1 |
interferon induced with helicase C domain 1 |
|
multiple interactions |
ISO |
2 |
62,433,850 |
62,484,312 |
RGD:6480464 |
CTD |
| G |
Ifih1 |
interferon induced with helicase C domain 1 |
|
increases expression |
ISO |
2 |
62,433,850 |
62,484,312 |
RGD:6480464 |
CTD |
| G |
Ifit1 |
interferon-induced protein with tetratricopeptide repeats 1 |
|
decreases expression |
ISO |
19 |
34,715,379 |
34,724,499 |
RGD:6480464 |
CTD |
| G |
Ifit1 |
interferon-induced protein with tetratricopeptide repeats 1 |
|
multiple interactions |
ISO |
19 |
34,715,379 |
34,724,499 |
RGD:6480464 |
CTD |
| G |
Ifit1 |
interferon-induced protein with tetratricopeptide repeats 1 |
|
increases expression |
ISO |
19 |
34,715,379 |
34,724,499 |
RGD:6480464 |
CTD |
| G |
Ifit1 |
interferon-induced protein with tetratricopeptide repeats 1 |
|
affects expression |
EXP |
19 |
34,715,379 |
34,724,499 |
RGD:6480464 |
CTD |
| G |
Ifit1 |
interferon-induced protein with tetratricopeptide repeats 1 |
|
increases expression |
EXP |
19 |
34,715,379 |
34,724,499 |
RGD:6480464 |
CTD |
| G |
Ifit3 |
interferon-induced protein with tetratricopeptide repeats 3 |
|
multiple interactions |
ISO |
19 |
34,658,019 |
34,663,472 |
RGD:6480464 |
CTD |
| G |
Ifit3 |
interferon-induced protein with tetratricopeptide repeats 3 |
|
increases expression |
ISO |
19 |
34,658,019 |
34,663,472 |
RGD:6480464 |
CTD |
| G |
Ifit3 |
interferon-induced protein with tetratricopeptide repeats 3 |
|
increases expression |
EXP |
19 |
34,658,019 |
34,663,472 |
RGD:6480464 |
CTD |
| G |
Ifitm1 |
interferon induced transmembrane protein 1 |
|
increases expression |
ISO |
7 |
148,153,328 |
148,155,726 |
RGD:6480464 |
CTD |
| G |
Ifitm1 |
interferon induced transmembrane protein 1 |
|
multiple interactions |
ISO |
7 |
148,153,328 |
148,155,726 |
RGD:6480464 |
CTD |
| G |
Ifng |
interferon gamma |
|
multiple interactions |
EXP |
10 |
117,878,103 |
117,882,948 |
RGD:6480464 |
CTD |
| G |
Ifng |
interferon gamma |
|
affects secretion |
EXP |
10 |
117,878,103 |
117,882,948 |
RGD:6480464 |
CTD |
| G |
Ifrd1 |
interferon-related developmental regulator 1 |
|
increases expression |
ISO |
12 |
40,929,716 |
40,949,776 |
RGD:6480464 |
CTD |
| G |
Ifrd1 |
interferon-related developmental regulator 1 |
|
affects expression |
EXP |
12 |
40,929,716 |
40,949,776 |
RGD:6480464 |
CTD |
| G |
Igf1 |
insulin-like growth factor 1 |
|
affects expression |
ISO |
10 |
87,321,801 |
87,399,792 |
RGD:6480464 |
CTD |
| G |
Igf1 |
insulin-like growth factor 1 |
|
increases expression |
ISO |
10 |
87,321,801 |
87,399,792 |
RGD:6480464 |
CTD |
| G |
Igf1 |
insulin-like growth factor 1 |
|
increases expression |
EXP |
10 |
87,321,801 |
87,399,792 |
RGD:6480464 |
CTD |
| G |
Igf1 |
insulin-like growth factor 1 |
|
multiple interactions |
ISO |
10 |
87,321,801 |
87,399,792 |
RGD:6480464 |
CTD |
| G |
Igf1 |
insulin-like growth factor 1 |
|
multiple interactions |
ISO |
10 |
87,321,801 |
87,399,792 |
RGD:6480464 |
CTD |
| G |
Igf1 |
insulin-like growth factor 1 |
|
decreases expression |
ISO |
10 |
87,321,801 |
87,399,792 |
RGD:6480464 |
CTD |
| G |
Igf1r |
insulin-like growth factor I receptor |
|
increases expression |
ISO |
7 |
75,097,143 |
75,378,553 |
RGD:6480464 |
CTD |
| G |
Igf1r |
insulin-like growth factor I receptor |
|
multiple interactions |
ISO |
7 |
75,097,143 |
75,378,553 |
RGD:6480464 |
CTD |
| G |
Igfbp3 |
insulin-like growth factor binding protein 3 |
|
increases expression |
ISO |
11 |
7,106,089 |
7,113,926 |
RGD:6480464 |
CTD |
| G |
Igfbp4 |
insulin-like growth factor binding protein 4 |
|
increases expression |
ISO |
11 |
98,902,574 |
98,913,960 |
RGD:6480464 |
CTD |
| G |
Igfbp5 |
insulin-like growth factor binding protein 5 |
|
affects expression |
ISO |
1 |
72,904,639 |
72,921,439 |
RGD:6480464 |
CTD |
| G |
Il1a |
interleukin 1 alpha |
|
multiple interactions |
ISO |
2 |
129,125,346 |
129,135,708 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
multiple interactions |
ISO |
2 |
129,190,315 |
129,196,856 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
multiple interactions |
ISO |
2 |
129,190,315 |
129,196,856 |
RGD:6480464 |
CTD |
| G |
Il20ra |
interleukin 20 receptor, alpha |
|
multiple interactions |
ISO |
10 |
19,432,393 |
19,479,859 |
RGD:6480464 |
CTD |
| G |
Il24 |
interleukin 24 |
|
affects expression |
ISO |
1 |
132,778,651 |
132,783,988 |
RGD:6480464 |
CTD |
| G |
Il24 |
interleukin 24 |
|
multiple interactions |
ISO |
1 |
132,778,651 |
132,783,988 |
RGD:6480464 |
CTD |
| G |
Il24 |
interleukin 24 |
|
decreases expression |
ISO |
1 |
132,778,651 |
132,783,988 |
RGD:6480464 |
CTD |
| G |
Il24 |
interleukin 24 |
|
increases expression |
ISO |
1 |
132,778,651 |
132,783,988 |
RGD:6480464 |
CTD |
| G |
Il24 |
interleukin 24 |
|
multiple interactions |
ISO |
1 |
132,778,651 |
132,783,988 |
RGD:6480464 |
CTD |
| G |
Il24 |
interleukin 24 |
|
multiple interactions |
ISO |
1 |
132,778,651 |
132,783,988 |
RGD:6480464 |
CTD |
| G |
Il27ra |
interleukin 27 receptor, alpha |
|
multiple interactions |
ISO |
8 |
86,554,185 |
86,566,474 |
RGD:6480464 |
CTD |
| G |
Il27ra |
interleukin 27 receptor, alpha |
|
increases expression |
ISO |
8 |
86,554,185 |
86,566,474 |
RGD:6480464 |
CTD |
| G |
Il2rb |
interleukin 2 receptor, beta chain |
|
multiple interactions |
ISO |
15 |
78,310,978 |
78,325,496 |
RGD:6480464 |
CTD |
| G |
Il33 |
interleukin 33 |
|
multiple interactions |
ISO |
19 |
29,999,604 |
30,035,205 |
RGD:6480464 |
CTD |
| G |
Il4 |
interleukin 4 |
|
decreases secretion |
EXP |
11 |
53,425,962 |
53,432,167 |
RGD:6480464 |
CTD |
| G |
Il4ra |
interleukin 4 receptor, alpha |
|
increases expression |
EXP |
7 |
132,695,796 |
132,722,988 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
decreases expression |
ISO |
5 |
30,339,701 |
30,346,508 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
multiple interactions |
ISO |
5 |
30,339,701 |
30,346,508 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
multiple interactions |
ISO |
5 |
30,339,701 |
30,346,508 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
decreases expression |
ISO |
5 |
30,339,701 |
30,346,508 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
increases expression |
ISO |
5 |
30,339,701 |
30,346,508 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
increases secretion |
ISO |
5 |
30,339,701 |
30,346,508 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
multiple interactions |
ISO |
5 |
30,339,701 |
30,346,508 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
multiple interactions |
EXP |
5 |
30,339,701 |
30,346,508 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
multiple interactions |
EXP |
5 |
30,339,701 |
30,346,508 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
decreases secretion |
EXP |
5 |
30,339,701 |
30,346,508 |
RGD:6480464 |
CTD |
| G |
Il6ra |
interleukin 6 receptor, alpha |
|
affects expression |
ISO |
3 |
89,673,246 |
89,717,084 |
RGD:6480464 |
CTD |
| G |
Il6st |
interleukin 6 signal transducer |
|
affects expression |
ISO |
13 |
113,254,278 |
113,297,068 |
RGD:6480464 |
CTD |
| G |
Il6st |
interleukin 6 signal transducer |
|
multiple interactions |
ISO |
13 |
113,254,278 |
113,297,068 |
RGD:6480464 |
CTD |
| G |
Il7r |
interleukin 7 receptor |
|
affects expression |
ISO |
15 |
9,435,914 |
9,459,631 |
RGD:6480464 |
CTD |
| G |
Il8 |
interleukin 8 |
|
multiple interactions |
ISO |
5 |
91,223,560 |
91,232,093 |
RGD:6480464 |
CTD |
| G |
Il8 |
interleukin 8 |
|
affects expression |
ISO |
5 |
91,223,560 |
91,232,093 |
RGD:6480464 |
CTD |
| G |
Il8 |
interleukin 8 |
|
multiple interactions |
ISO |
5 |
91,223,560 |
91,232,093 |
RGD:6480464 |
CTD |
| G |
Il8 |
interleukin 8 |
|
multiple interactions |
ISO |
5 |
91,223,560 |
91,232,093 |
RGD:6480464 |
CTD |
| G |
Il8 |
interleukin 8 |
|
multiple interactions |
ISO |
5 |
91,223,560 |
91,232,093 |
RGD:6480464 |
CTD |
| G |
Il8 |
interleukin 8 |
|
decreases expression |
ISO |
5 |
91,223,560 |
91,232,093 |
RGD:6480464 |
CTD |
| G |
Il8 |
interleukin 8 |
|
decreases secretion |
ISO |
5 |
91,223,560 |
91,232,093 |
RGD:6480464 |
CTD |
| G |
Il8 |
interleukin 8 |
|
increases expression |
ISO |
5 |
91,223,560 |
91,232,093 |
RGD:6480464 |
CTD |
| G |
Il8 |
interleukin 8 |
|
increases secretion |
ISO |
5 |
91,223,560 |
91,232,093 |
RGD:6480464 |
CTD |
| G |
Il8 |
interleukin 8 |
|
multiple interactions |
ISO |
5 |
91,223,560 |
91,232,093 |
RGD:6480464 |
CTD |
| G |
Ilf2 |
interleukin enhancer binding factor 2 |
|
increases expression |
ISO |
3 |
90,280,123 |
90,292,301 |
RGD:6480464 |
CTD |
| G |
Inha |
inhibin alpha |
|
decreases expression |
EXP |
1 |
75,503,652 |
75,506,929 |
RGD:6480464 |
CTD |
| G |
Inhba |
inhibin beta-A |
|
multiple interactions |
ISO |
13 |
16,106,308 |
16,119,044 |
RGD:6480464 |
CTD |
| G |
Inhba |
inhibin beta-A |
|
decreases expression |
EXP |
13 |
16,106,308 |
16,119,044 |
RGD:6480464 |
CTD |
| G |
Inhbb |
inhibin beta-B |
|
increases expression |
EXP |
1 |
121,312,042 |
121,318,825 |
RGD:6480464 |
CTD |
| G |
Inhbb |
inhibin beta-B |
|
decreases expression |
EXP |
1 |
121,312,042 |
121,318,825 |
RGD:6480464 |
CTD |
| G |
Inhbb |
inhibin beta-B |
|
increases expression |
EXP |
1 |
121,312,042 |
121,318,825 |
RGD:6480464 |
CTD |
| G |
Inhbe |
inhibin beta E |
|
multiple interactions |
ISO |
10 |
126,786,458 |
126,788,828 |
RGD:6480464 |
CTD |
| G |
Inhbe |
inhibin beta E |
|
decreases expression |
ISO |
10 |
126,786,458 |
126,788,828 |
RGD:6480464 |
CTD |
| G |
Inhbe |
inhibin beta E |
|
increases expression |
ISO |
10 |
126,786,458 |
126,788,828 |
RGD:6480464 |
CTD |
| G |
Inpp5k |
inositol polyphosphate 5-phosphatase K |
|
decreases expression |
EXP |
11 |
75,444,522 |
75,462,367 |
RGD:6480464 |
CTD |
| G |
Ins1 |
insulin I |
|
decreases expression |
ISO |
19 |
52,338,813 |
52,339,966 |
RGD:6480464 |
CTD |
| G |
Ins1 |
insulin I |
|
increases expression |
ISO |
19 |
52,338,813 |
52,339,966 |
RGD:6480464 |
CTD |
| G |
Ins1 |
insulin I |
|
multiple interactions |
EXP |
19 |
52,338,813 |
52,339,966 |
RGD:6480464 |
CTD |
| G |
Ins1 |
insulin I |
|
multiple interactions |
ISO |
19 |
52,338,813 |
52,339,966 |
RGD:6480464 |
CTD |
| G |
Ins2 |
insulin II |
|
multiple interactions |
ISO |
7 |
149,864,561 |
149,865,613 |
RGD:6480464 |
CTD |
| G |
Ins2 |
insulin II |
|
multiple interactions |
EXP |
7 |
149,864,561 |
149,865,613 |
RGD:6480464 |
CTD |
| G |
Insig1 |
insulin induced gene 1 |
|
affects expression |
ISO |
5 |
28,397,952 |
28,405,202 |
RGD:6480464 |
CTD |
| G |
Insr |
insulin receptor |
|
decreases expression |
ISO |
8 |
3,150,922 |
3,279,617 |
RGD:6480464 |
CTD |
| G |
Irak1 |
interleukin-1 receptor-associated kinase 1 |
|
affects expression |
ISO |
X |
71,259,253 |
71,269,260 |
RGD:6480464 |
CTD |
| G |
Irs1 |
insulin receptor substrate 1 |
|
increases expression |
ISO |
1 |
82,229,680 |
82,288,014 |
RGD:6480464 |
CTD |
| G |
Irs1 |
insulin receptor substrate 1 |
|
decreases expression |
ISO |
1 |
82,229,680 |
82,288,014 |
RGD:6480464 |
CTD |
| G |
Jun |
Jun oncogene |
|
increases expression |
ISO |
4 |
94,715,727 |
94,718,913 |
RGD:6480464 |
CTD |
| G |
Jun |
Jun oncogene |
|
increases expression |
EXP |
4 |
94,715,727 |
94,718,913 |
RGD:6480464 |
CTD |
| G |
Jun |
Jun oncogene |
|
increases expression |
EXP |
4 |
94,715,727 |
94,718,913 |
RGD:6480464 |
CTD |
| G |
Kcnj16 |
potassium inwardly-rectifying channel, subfamily J, member 16 |
|
decreases expression |
ISO |
11 |
110,829,347 |
110,889,282 |
RGD:6480464 |
CTD |
| G |
Kcnj8 |
potassium inwardly-rectifying channel, subfamily J, member 8 |
|
multiple interactions |
ISO |
6 |
142,513,459 |
142,519,876 |
RGD:6480464 |
CTD |
| G |
Kcnj8 |
potassium inwardly-rectifying channel, subfamily J, member 8 |
|
decreases expression |
ISO |
6 |
142,513,459 |
142,519,876 |
RGD:6480464 |
CTD |
| G |
Kcnj8 |
potassium inwardly-rectifying channel, subfamily J, member 8 |
|
multiple interactions |
ISO |
6 |
142,513,459 |
142,519,876 |
RGD:6480464 |
CTD |
| G |
Kcnma1 |
potassium large conductance calcium-activated channel, subfamily M, alpha member 1 |
|
increases activity |
ISO |
14 |
24,117,983 |
24,823,427 |
RGD:6480464 |
CTD |
| G |
Kcnma1 |
potassium large conductance calcium-activated channel, subfamily M, alpha member 1 |
|
multiple interactions |
ISO |
14 |
24,117,983 |
24,823,427 |
RGD:6480464 |
CTD |
| G |
Kcnma1 |
potassium large conductance calcium-activated channel, subfamily M, alpha member 1 |
|
decreases expression |
ISO |
14 |
24,117,983 |
24,823,427 |
RGD:6480464 |
CTD |
| G |
Kcnma1 |
potassium large conductance calcium-activated channel, subfamily M, alpha member 1 |
|
multiple interactions |
ISO |
14 |
24,117,983 |
24,823,427 |
RGD:6480464 |
CTD |
| G |
Kcnmb1 |
potassium large conductance calcium-activated channel, subfamily M, beta member 1 |
|
increases expression |
ISO |
11 |
33,863,013 |
33,873,638 |
RGD:6480464 |
CTD |
| G |
Kcnn4 |
potassium intermediate/small conductance calcium-activated channel, subfamily N, member 4 |
|
increases expression |
EXP |
7 |
25,155,282 |
25,170,231 |
RGD:6480464 |
CTD |
| G |
Kcnn4 |
potassium intermediate/small conductance calcium-activated channel, subfamily N, member 4 |
|
affects expression |
ISO |
7 |
25,155,282 |
25,170,231 |
RGD:6480464 |
CTD |
| G |
Kctd12 |
potassium channel tetramerisation domain containing 12 |
|
decreases expression |
EXP |
14 |
103,375,798 |
103,381,854 |
RGD:6480464 |
CTD |
| G |
Kdr |
kinase insert domain protein receptor |
|
multiple interactions |
EXP |
5 |
76,329,290 |
76,374,453 |
RGD:6480464 |
CTD |
| G |
Kdr |
kinase insert domain protein receptor |
|
multiple interactions |
ISO |
5 |
76,329,290 |
76,374,453 |
RGD:6480464 |
CTD |
| G |
Kdr |
kinase insert domain protein receptor |
|
increases expression |
ISO |
5 |
76,329,290 |
76,374,453 |
RGD:6480464 |
CTD |
| G |
Kdr |
kinase insert domain protein receptor |
|
increases expression |
EXP |
5 |
76,329,290 |
76,374,453 |
RGD:6480464 |
CTD |
| G |
Khk |
ketohexokinase |
|
decreases expression |
ISO |
5 |
31,224,268 |
31,233,619 |
RGD:6480464 |
CTD |
| G |
Kif11 |
kinesin family member 11 |
|
increases expression |
ISO |
19 |
37,450,893 |
37,496,349 |
RGD:6480464 |
CTD |
| G |
Kif14 |
kinesin family member 14 |
|
increases expression |
ISO |
1 |
138,364,535 |
138,428,088 |
RGD:6480464 |
CTD |
| G |
Kif15 |
kinesin family member 15 |
|
increases expression |
ISO |
9 |
122,860,199 |
122,927,851 |
RGD:6480464 |
CTD |
| G |
Kif15 |
kinesin family member 15 |
|
increases expression |
ISO |
9 |
122,860,199 |
122,927,851 |
RGD:6480464 |
CTD |
| G |
Kif1a |
kinesin family member 1A |
|
decreases expression |
ISO |
1 |
94,912,033 |
94,998,442 |
RGD:6480464 |
CTD |
| G |
Kif20a |
kinesin family member 20A |
|
increases expression |
ISO |
18 |
34,784,278 |
34,792,931 |
RGD:6480464 |
CTD |
| G |
Kif20a |
kinesin family member 20A |
|
increases expression |
ISO |
18 |
34,784,278 |
34,792,931 |
RGD:6480464 |
CTD |
| G |
Kif23 |
kinesin family member 23 |
|
increases expression |
ISO |
9 |
61,765,084 |
61,794,606 |
RGD:6480464 |
CTD |
| G |
Kif2c |
kinesin family member 2C |
|
increases expression |
ISO |
4 |
116,832,239 |
116,855,229 |
RGD:6480464 |
CTD |
| G |
Kif3c |
kinesin family member 3C |
|
decreases expression |
ISO |
12 |
3,365,132 |
3,406,494 |
RGD:6480464 |
CTD |
| G |
Kif4 |
kinesin family member 4 |
|
increases expression |
ISO |
X |
97,821,404 |
97,922,610 |
RGD:6480464 |
CTD |
| G |
Kiss1 |
KiSS-1 metastasis-suppressor |
|
increases expression |
EXP |
1 |
135,223,789 |
135,226,299 |
RGD:6480464 |
CTD |
| G |
Kiss1 |
KiSS-1 metastasis-suppressor |
|
decreases expression |
EXP |
1 |
135,223,789 |
135,226,299 |
RGD:6480464 |
CTD |
| G |
Kit |
kit oncogene |
|
affects expression |
EXP |
5 |
75,971,012 |
76,052,747 |
RGD:6480464 |
CTD |
| G |
Klf10 |
Kruppel-like factor 10 |
|
multiple interactions |
ISO |
15 |
38,224,168 |
38,230,462 |
RGD:6480464 |
CTD |
| G |
Klf10 |
Kruppel-like factor 10 |
|
decreases expression |
ISO |
15 |
38,224,168 |
38,230,462 |
RGD:6480464 |
CTD |
| G |
Klf10 |
Kruppel-like factor 10 |
|
affects expression |
EXP |
15 |
38,224,168 |
38,230,462 |
RGD:6480464 |
CTD |
| G |
Klf10 |
Kruppel-like factor 10 |
|
affects expression |
ISO |
15 |
38,224,168 |
38,230,462 |
RGD:6480464 |
CTD |
| G |
Klf4 |
Kruppel-like factor 4 (gut) |
|
multiple interactions |
ISO |
4 |
55,540,009 |
55,545,347 |
RGD:6480464 |
CTD |
| G |
Klf4 |
Kruppel-like factor 4 (gut) |
|
increases expression |
ISO |
4 |
55,540,009 |
55,545,347 |
RGD:6480464 |
CTD |
| G |
Klf6 |
Kruppel-like factor 6 |
|
increases expression |
ISO |
13 |
5,860,735 |
5,869,639 |
RGD:6480464 |
CTD |
| G |
Klk11 |
kallikrein related-peptidase 11 |
|
multiple interactions |
ISO |
7 |
51,029,987 |
51,034,633 |
RGD:6480464 |
CTD |
| G |
Klk11 |
kallikrein related-peptidase 11 |
|
increases expression |
ISO |
7 |
51,029,987 |
51,034,633 |
RGD:6480464 |
CTD |
| G |
Klk1b1 |
kallikrein 1-related peptidase b1 |
|
affects expression |
EXP |
7 |
51,222,138 |
51,226,686 |
RGD:6480464 |
CTD |
| G |
Klk1b22 |
kallikrein 1-related peptidase b22 |
|
affects expression |
EXP |
7 |
51,368,053 |
51,372,246 |
RGD:6480464 |
CTD |
| G |
Klk1b27 |
kallikrein 1-related peptidase b27 |
|
multiple interactions |
ISO |
7 |
51,307,660 |
51,312,082 |
RGD:6480464 |
CTD |
| G |
Klk1b27 |
kallikrein 1-related peptidase b27 |
|
multiple interactions |
ISO |
7 |
51,307,660 |
51,312,082 |
RGD:6480464 |
CTD |
| G |
Klk1b27 |
kallikrein 1-related peptidase b27 |
|
increases expression |
ISO |
7 |
51,307,660 |
51,312,082 |
RGD:6480464 |
CTD |
| G |
Klk1b27 |
kallikrein 1-related peptidase b27 |
|
multiple interactions |
ISO |
7 |
51,307,660 |
51,312,082 |
RGD:6480464 |
CTD |
| G |
Klk1b27 |
kallikrein 1-related peptidase b27 |
|
increases expression |
ISO |
7 |
51,307,660 |
51,312,082 |
RGD:6480464 |
CTD |
| G |
Klk1b27 |
kallikrein 1-related peptidase b27 |
|
increases secretion |
ISO |
7 |
51,307,660 |
51,312,082 |
RGD:6480464 |
CTD |
| G |
Klk1b27 |
kallikrein 1-related peptidase b27 |
|
multiple interactions |
ISO |
7 |
51,307,660 |
51,312,082 |
RGD:6480464 |
CTD |
| G |
Klk1b27 |
kallikrein 1-related peptidase b27 |
|
increases expression |
ISO |
7 |
51,307,660 |
51,312,082 |
RGD:6480464 |
CTD |
| G |
Klk1b27 |
kallikrein 1-related peptidase b27 |
|
multiple interactions |
ISO |
7 |
51,307,660 |
51,312,082 |
RGD:6480464 |
CTD |
| G |
Klk1b27 |
kallikrein 1-related peptidase b27 |
|
increases expression |
ISO |
7 |
51,307,660 |
51,312,082 |
RGD:6480464 |
CTD |
| G |
Klk6 |
kallikrein related-peptidase 6 |
|
increases expression |
ISO |
7 |
51,079,914 |
51,087,397 |
RGD:6480464 |
CTD |
| G |
Klk6 |
kallikrein related-peptidase 6 |
|
multiple interactions |
ISO |
7 |
51,079,914 |
51,087,397 |
RGD:6480464 |
CTD |
| G |
Kpna2 |
karyopherin (importin) alpha 2 |
|
increases expression |
ISO |
11 |
106,849,943 |
106,860,839 |
RGD:6480464 |
CTD |
| G |
Lgals8 |
lectin, galactose binding, soluble 8 |
|
multiple interactions |
ISO |
13 |
12,531,686 |
12,553,757 |
RGD:6480464 |
CTD |
| G |
Lgals8 |
lectin, galactose binding, soluble 8 |
|
increases expression |
ISO |
13 |
12,531,686 |
12,553,757 |
RGD:6480464 |
CTD |
| G |
Lgmn |
legumain |
|
affects expression |
EXP |
12 |
103,632,308 |
103,677,907 |
RGD:6480464 |
CTD |
| G |
Lhb |
luteinizing hormone beta |
|
multiple interactions |
ISO |
7 |
52,673,729 |
52,675,734 |
RGD:6480464 |
CTD |
| G |
Lhb |
luteinizing hormone beta |
|
multiple interactions |
ISO |
7 |
52,673,729 |
52,675,734 |
RGD:6480464 |
CTD |
| G |
Lhb |
luteinizing hormone beta |
|
increases secretion |
ISO |
7 |
52,673,729 |
52,675,734 |
RGD:6480464 |
CTD |
| G |
Lhb |
luteinizing hormone beta |
|
multiple interactions |
ISO |
7 |
52,673,729 |
52,675,734 |
RGD:6480464 |
CTD |
| G |
Lhb |
luteinizing hormone beta |
|
multiple interactions |
ISO |
7 |
52,673,729 |
52,675,734 |
RGD:6480464 |
CTD |
| G |
Lhb |
luteinizing hormone beta |
|
decreases expression |
ISO |
7 |
52,673,729 |
52,675,734 |
RGD:6480464 |
CTD |
| G |
Lhb |
luteinizing hormone beta |
|
decreases secretion |
ISO |
7 |
52,673,729 |
52,675,734 |
RGD:6480464 |
CTD |
| G |
Lhb |
luteinizing hormone beta |
|
multiple interactions |
ISO |
7 |
52,673,729 |
52,675,734 |
RGD:6480464 |
CTD |
| G |
Lhb |
luteinizing hormone beta |
|
multiple interactions |
ISO |
7 |
52,673,729 |
52,675,734 |
RGD:6480464 |
CTD |
| G |
Lhb |
luteinizing hormone beta |
|
multiple interactions |
ISO |
7 |
52,673,729 |
52,675,734 |
RGD:6480464 |
CTD |
| G |
Lhb |
luteinizing hormone beta |
|
multiple interactions |
ISO |
7 |
52,673,729 |
52,675,734 |
RGD:6480464 |
CTD |
| G |
Lhb |
luteinizing hormone beta |
|
decreases expression |
ISO |
7 |
52,673,729 |
52,675,734 |
RGD:6480464 |
CTD |
| G |
Lhb |
luteinizing hormone beta |
|
decreases expression |
ISO |
7 |
52,673,729 |
52,675,734 |
RGD:6480464 |
CTD |
| G |
Lhb |
luteinizing hormone beta |
|
decreases secretion |
ISO |
7 |
52,673,729 |
52,675,734 |
RGD:6480464 |
CTD |
| G |
Lhb |
luteinizing hormone beta |
|
increases secretion |
ISO |
7 |
52,673,729 |
52,675,734 |
RGD:6480464 |
CTD |
| G |
Lhb |
luteinizing hormone beta |
|
multiple interactions |
ISO |
7 |
52,673,729 |
52,675,734 |
RGD:6480464 |
CTD |
| G |
Lif |
leukemia inhibitory factor |
|
multiple interactions |
ISO |
11 |
4,157,571 |
4,172,517 |
RGD:6480464 |
CTD |
| G |
Lif |
leukemia inhibitory factor |
|
multiple interactions |
EXP |
11 |
4,157,571 |
4,172,517 |
RGD:6480464 |
CTD |
| G |
Lif |
leukemia inhibitory factor |
|
multiple interactions |
EXP |
11 |
4,157,571 |
4,172,517 |
RGD:6480464 |
CTD |
| G |
Lifr |
leukemia inhibitory factor receptor |
|
increases expression |
EXP |
15 |
7,079,572 |
7,147,489 |
RGD:6480464 |
CTD |
| G |
Limch1 |
LIM and calponin homology domains 1 |
|
multiple interactions |
ISO |
5 |
67,137,079 |
67,448,398 |
RGD:6480464 |
CTD |
| G |
Limch1 |
LIM and calponin homology domains 1 |
|
increases expression |
ISO |
5 |
67,137,079 |
67,448,398 |
RGD:6480464 |
CTD |
| G |
Lin7a |
lin-7 homolog A (C. elegans) |
|
decreases expression |
ISO |
10 |
106,708,887 |
106,862,199 |
RGD:6480464 |
CTD |
| G |
Lin7a |
lin-7 homolog A (C. elegans) |
|
multiple interactions |
ISO |
10 |
106,708,887 |
106,862,199 |
RGD:6480464 |
CTD |
| G |
Lin7a |
lin-7 homolog A (C. elegans) |
|
decreases expression |
ISO |
10 |
106,708,887 |
106,862,199 |
RGD:6480464 |
CTD |
| G |
Lipc |
lipase, hepatic |
|
increases expression |
ISO |
9 |
70,645,935 |
70,782,615 |
RGD:6480464 |
CTD |
| G |
Lipg |
lipase, endothelial |
|
decreases expression |
ISO |
18 |
75,098,976 |
75,120,917 |
RGD:6480464 |
CTD |
| G |
Llgl2 |
lethal giant larvae homolog 2 (Drosophila) |
|
multiple interactions |
ISO |
11 |
115,685,372 |
115,717,094 |
RGD:6480464 |
CTD |
| G |
Lmcd1 |
LIM and cysteine-rich domains 1 |
|
multiple interactions |
ISO |
6 |
112,223,752 |
112,280,417 |
RGD:6480464 |
CTD |
| G |
Lmcd1 |
LIM and cysteine-rich domains 1 |
|
increases expression |
ISO |
6 |
112,223,752 |
112,280,417 |
RGD:6480464 |
CTD |
| G |
Lmnb1 |
lamin B1 |
|
decreases expression |
ISO |
18 |
56,867,467 |
56,913,078 |
RGD:6480464 |
CTD |
| G |
Lox |
lysyl oxidase |
|
decreases expression |
ISO |
18 |
52,676,892 |
52,689,362 |
RGD:6480464 |
CTD |
| G |
Lox |
lysyl oxidase |
|
affects expression |
ISO |
18 |
52,676,892 |
52,689,362 |
RGD:6480464 |
CTD |
| G |
Loxl1 |
lysyl oxidase-like 1 |
|
multiple interactions |
ISO |
9 |
58,135,530 |
58,161,019 |
RGD:6480464 |
CTD |
| G |
Loxl1 |
lysyl oxidase-like 1 |
|
increases expression |
ISO |
9 |
58,135,530 |
58,161,019 |
RGD:6480464 |
CTD |
| G |
Lpar1 |
lysophosphatidic acid receptor 1 |
|
affects expression |
ISO |
4 |
58,448,124 |
58,566,363 |
RGD:6480464 |
CTD |
| G |
Lpar1 |
lysophosphatidic acid receptor 1 |
|
affects expression |
EXP |
4 |
58,448,124 |
58,566,363 |
RGD:6480464 |
CTD |
| G |
Lpin1 |
lipin 1 |
|
decreases expression |
ISO |
12 |
16,542,475 |
16,596,576 |
RGD:6480464 |
CTD |
| G |
Lpl |
lipoprotein lipase |
|
multiple interactions |
EXP |
8 |
71,404,454 |
71,430,831 |
RGD:6480464 |
CTD |
| G |
Lpl |
lipoprotein lipase |
|
affects expression |
ISO |
8 |
71,404,454 |
71,430,831 |
RGD:6480464 |
CTD |
| G |
Lpl |
lipoprotein lipase |
|
decreases expression |
EXP |
8 |
71,404,454 |
71,430,831 |
RGD:6480464 |
CTD |
| G |
Lpl |
lipoprotein lipase |
|
increases expression |
EXP |
8 |
71,404,454 |
71,430,831 |
RGD:6480464 |
CTD |
| G |
Lpl |
lipoprotein lipase |
|
increases expression |
ISO |
8 |
71,404,454 |
71,430,831 |
RGD:6480464 |
CTD |
| G |
Lpo |
lactoperoxidase |
|
affects expression |
ISO |
11 |
87,619,930 |
87,639,616 |
RGD:6480464 |
CTD |
| G |
Lpo |
lactoperoxidase |
|
multiple interactions |
ISO |
11 |
87,619,930 |
87,639,616 |
RGD:6480464 |
CTD |
| G |
Lrg1 |
leucine-rich alpha-2-glycoprotein 1 |
|
affects expression |
EXP |
17 |
56,259,101 |
56,261,369 |
RGD:6480464 |
CTD |
| G |
Lrg1 |
leucine-rich alpha-2-glycoprotein 1 |
|
increases expression |
EXP |
17 |
56,259,101 |
56,261,369 |
RGD:6480464 |
CTD |
| G |
Lrp1 |
low density lipoprotein receptor-related protein 1 |
|
multiple interactions |
EXP |
10 |
126,975,213 |
127,058,204 |
RGD:6480464 |
CTD |
| G |
Lrp5 |
low density lipoprotein receptor-related protein 5 |
|
multiple interactions |
ISO |
19 |
3,584,825 |
3,686,564 |
RGD:6480464 |
CTD |
| G |
Ltf |
lactotransferrin |
|
increases expression |
EXP |
9 |
110,921,796 |
110,945,270 |
RGD:6480464 |
CTD |
| G |
Ltf |
lactotransferrin |
|
multiple interactions |
EXP |
9 |
110,921,796 |
110,945,270 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen-activated protein kinase 1 |
|
decreases phosphorylation |
ISO |
16 |
16,983,475 |
17,047,546 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen-activated protein kinase 1 |
|
increases phosphorylation |
ISO |
16 |
16,983,475 |
17,047,546 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen-activated protein kinase 1 |
|
multiple interactions |
ISO |
16 |
16,983,475 |
17,047,546 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen-activated protein kinase 1 |
|
multiple interactions |
ISO |
16 |
16,983,475 |
17,047,546 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen-activated protein kinase 1 |
|
multiple interactions |
EXP |
16 |
16,983,475 |
17,047,546 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen-activated protein kinase 1 |
|
increases phosphorylation |
EXP |
16 |
16,983,475 |
17,047,546 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen-activated protein kinase 1 |
|
multiple interactions |
ISO |
16 |
16,983,475 |
17,047,546 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen-activated protein kinase 1 |
|
affects phosphorylation |
ISO |
16 |
16,983,475 |
17,047,546 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen-activated protein kinase 1 |
|
increases activity |
ISO |
16 |
16,983,475 |
17,047,546 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen-activated protein kinase 1 |
|
increases phosphorylation |
ISO |
16 |
16,983,475 |
17,047,546 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen-activated protein kinase 1 |
|
multiple interactions |
ISO |
16 |
16,983,475 |
17,047,546 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen-activated protein kinase 1 |
|
multiple interactions |
ISO |
16 |
16,983,475 |
17,047,546 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen-activated protein kinase 1 |
|
multiple interactions |
ISO |
16 |
16,983,475 |
17,047,546 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen-activated protein kinase 1 |
|
increases phosphorylation |
ISO |
16 |
16,983,475 |
17,047,546 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen-activated protein kinase 1 |
|
multiple interactions |
ISO |
16 |
16,983,475 |
17,047,546 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen-activated protein kinase 1 |
|
multiple interactions |
ISO |
16 |
16,983,475 |
17,047,546 |
RGD:6480464 |
CTD |
| G |
Mapk14 |
mitogen-activated protein kinase 14 |
|
increases activity |
ISO |
17 |
28,828,287 |
28,885,350 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen-activated protein kinase 3 |
|
multiple interactions |
ISO |
7 |
133,903,140 |
133,909,330 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen-activated protein kinase 3 |
|
increases phosphorylation |
ISO |
7 |
133,903,140 |
133,909,330 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen-activated protein kinase 3 |
|
multiple interactions |
ISO |
7 |
133,903,140 |
133,909,330 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen-activated protein kinase 3 |
|
multiple interactions |
ISO |
7 |
133,903,140 |
133,909,330 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen-activated protein kinase 3 |
|
multiple interactions |
EXP |
7 |
133,903,140 |
133,909,330 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen-activated protein kinase 3 |
|
increases phosphorylation |
EXP |
7 |
133,903,140 |
133,909,330 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen-activated protein kinase 3 |
|
multiple interactions |
ISO |
7 |
133,903,140 |
133,909,330 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen-activated protein kinase 3 |
|
affects phosphorylation |
ISO |
7 |
133,903,140 |
133,909,330 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen-activated protein kinase 3 |
|
increases activity |
ISO |
7 |
133,903,140 |
133,909,330 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen-activated protein kinase 3 |
|
increases phosphorylation |
ISO |
7 |
133,903,140 |
133,909,330 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen-activated protein kinase 3 |
|
multiple interactions |
ISO |
7 |
133,903,140 |
133,909,330 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen-activated protein kinase 3 |
|
multiple interactions |
ISO |
7 |
133,903,140 |
133,909,330 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen-activated protein kinase 3 |
|
multiple interactions |
ISO |
7 |
133,903,140 |
133,909,330 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen-activated protein kinase 3 |
|
multiple interactions |
ISO |
7 |
133,903,140 |
133,909,330 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen-activated protein kinase 3 |
|
multiple interactions |
ISO |
7 |
133,903,140 |
133,909,330 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen-activated protein kinase 3 |
|
multiple interactions |
ISO |
7 |
133,903,140 |
133,909,330 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen-activated protein kinase 3 |
|
multiple interactions |
ISO |
7 |
133,903,140 |
133,909,330 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen-activated protein kinase 3 |
|
multiple interactions |
ISO |
7 |
133,903,140 |
133,909,330 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen-activated protein kinase 3 |
|
multiple interactions |
ISO |
7 |
133,903,140 |
133,909,330 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen-activated protein kinase 3 |
|
decreases expression |
ISO |
7 |
133,903,140 |
133,909,330 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen-activated protein kinase 3 |
|
decreases phosphorylation |
ISO |
7 |
133,903,140 |
133,909,330 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen-activated protein kinase 3 |
|
increases phosphorylation |
ISO |
7 |
133,903,140 |
133,909,330 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen-activated protein kinase 3 |
|
multiple interactions |
ISO |
7 |
133,903,140 |
133,909,330 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen-activated protein kinase 3 |
|
multiple interactions |
ISO |
7 |
133,903,140 |
133,909,330 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen-activated protein kinase 3 |
|
multiple interactions |
ISO |
7 |
133,903,140 |
133,909,330 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen-activated protein kinase 3 |
|
multiple interactions |
ISO |
7 |
133,903,140 |
133,909,330 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen-activated protein kinase 3 |
|
multiple interactions |
ISO |
7 |
133,903,140 |
133,909,330 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen-activated protein kinase 3 |
|
multiple interactions |
EXP |
7 |
133,903,140 |
133,909,330 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen-activated protein kinase 3 |
|
affects expression |
EXP |
7 |
133,903,140 |
133,909,330 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen-activated protein kinase 3 |
|
decreases phosphorylation |
EXP |
7 |
133,903,140 |
133,909,330 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen-activated protein kinase 3 |
|
increases phosphorylation |
EXP |
7 |
133,903,140 |
133,909,330 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen-activated protein kinase 3 |
|
multiple interactions |
EXP |
7 |
133,903,140 |
133,909,330 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen-activated protein kinase 3 |
|
multiple interactions |
ISO |
7 |
133,903,140 |
133,909,330 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen-activated protein kinase 3 |
|
multiple interactions |
ISO |
7 |
133,903,140 |
133,909,330 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen-activated protein kinase 3 |
|
multiple interactions |
ISO |
7 |
133,903,140 |
133,909,330 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen-activated protein kinase 3 |
|
multiple interactions |
ISO |
7 |
133,903,140 |
133,909,330 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen-activated protein kinase 3 |
|
multiple interactions |
ISO |
7 |
133,903,140 |
133,909,330 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen-activated protein kinase 3 |
|
increases phosphorylation |
ISO |
7 |
133,903,140 |
133,909,330 |
RGD:6480464 |
CTD |
| G |
Mapk8 |
mitogen-activated protein kinase 8 |
|
decreases expression |
ISO |
14 |
34,191,084 |
34,260,344 |
RGD:6480464 |
CTD |
| G |
Mapk8 |
mitogen-activated protein kinase 8 |
|
multiple interactions |
ISO |
14 |
34,191,084 |
34,260,344 |
RGD:6480464 |
CTD |
| G |
Mapkapk2 |
MAP kinase-activated protein kinase 2 |
|
affects expression |
EXP |
1 |
132,950,281 |
132,994,120 |
RGD:6480464 |
CTD |
| G |
Mapre1 |
microtubule-associated protein, RP/EB family, member 1 |
|
increases expression |
EXP |
2 |
153,567,023 |
153,599,053 |
RGD:6480464 |
CTD |
| G |
Mapt |
microtubule-associated protein tau |
|
multiple interactions |
ISO |
11 |
104,092,750 |
104,193,410 |
RGD:6480464 |
CTD |
| G |
Mapt |
microtubule-associated protein tau |
|
increases expression |
ISO |
11 |
104,092,750 |
104,193,410 |
RGD:6480464 |
CTD |
| G |
Marcks |
myristoylated alanine rich protein kinase C substrate |
|
multiple interactions |
ISO |
10 |
36,853,049 |
36,858,732 |
RGD:6480464 |
CTD |
| G |
Marcks |
myristoylated alanine rich protein kinase C substrate |
|
increases expression |
ISO |
10 |
36,853,049 |
36,858,732 |
RGD:6480464 |
CTD |
| G |
Maz |
MYC-associated zinc finger protein (purine-binding transcription factor) |
|
affects expression |
ISO |
7 |
134,165,648 |
134,169,993 |
RGD:6480464 |
CTD |
| G |
Mcm10 |
minichromosome maintenance deficient 10 (S. cerevisiae) |
|
increases expression |
ISO |
2 |
4,911,770 |
4,933,837 |
RGD:6480464 |
CTD |
| G |
Mcm3 |
minichromosome maintenance deficient 3 (S. cerevisiae) |
|
increases expression |
ISO |
1 |
20,793,095 |
20,810,294 |
RGD:6480464 |
CTD |
| G |
Med6 |
mediator of RNA polymerase II transcription, subunit 6 homolog (yeast) |
|
affects expression |
ISO |
12 |
82,674,551 |
82,695,945 |
RGD:6480464 |
CTD |
| G |
Mfsd10 |
major facilitator superfamily domain containing 10 |
|
affects expression |
ISO |
5 |
34,976,296 |
34,979,763 |
RGD:6480464 |
CTD |
| G |
Mgp |
matrix Gla protein |
|
increases expression |
ISO |
6 |
136,820,956 |
136,824,326 |
RGD:6480464 |
CTD |
| G |
Mki67 |
antigen identified by monoclonal antibody Ki 67 |
|
increases expression |
EXP |
7 |
142,881,471 |
142,908,062 |
RGD:6480464 |
CTD |
| G |
Mki67 |
antigen identified by monoclonal antibody Ki 67 |
|
multiple interactions |
EXP |
7 |
142,881,471 |
142,908,062 |
RGD:6480464 |
CTD |
| G |
Mki67 |
antigen identified by monoclonal antibody Ki 67 |
|
increases expression |
ISO |
7 |
142,881,471 |
142,908,062 |
RGD:6480464 |
CTD |
| G |
Mlf1ip |
myeloid leukemia factor 1 interacting protein |
|
increases expression |
ISO |
8 |
47,637,423 |
47,664,938 |
RGD:6480464 |
CTD |
| G |
Mll5 |
myeloid/lymphoid or mixed-lineage leukemia 5 |
|
decreases expression |
ISO |
5 |
22,940,247 |
23,010,047 |
RGD:6480464 |
CTD |
| G |
Mme |
membrane metallo endopeptidase |
|
decreases expression |
ISO |
3 |
63,099,794 |
63,186,153 |
RGD:6480464 |
CTD |
| G |
Mmp10 |
matrix metallopeptidase 10 |
|
increases expression |
ISO |
9 |
7,502,360 |
7,510,240 |
RGD:6480464 |
CTD |
| G |
Mmp11 |
matrix metallopeptidase 11 |
|
multiple interactions |
ISO |
10 |
75,385,969 |
75,395,208 |
RGD:6480464 |
CTD |
| G |
Mmp12 |
matrix metallopeptidase 12 |
|
multiple interactions |
ISO |
9 |
7,347,374 |
7,360,461 |
RGD:6480464 |
CTD |
| G |
Mmp12 |
matrix metallopeptidase 12 |
|
affects expression |
ISO |
9 |
7,347,374 |
7,360,461 |
RGD:6480464 |
CTD |
| G |
Mmp14 |
matrix metallopeptidase 14 (membrane-inserted) |
|
multiple interactions |
ISO |
14 |
55,050,441 |
55,060,095 |
RGD:6480464 |
CTD |
| G |
Mmp15 |
matrix metallopeptidase 15 |
|
decreases expression |
ISO |
8 |
97,876,237 |
97,898,193 |
RGD:6480464 |
CTD |
| G |
Mmp1a |
matrix metallopeptidase 1a (interstitial collagenase) |
|
multiple interactions |
ISO |
9 |
7,464,141 |
7,476,869 |
RGD:6480464 |
CTD |
| G |
Mmp1a |
matrix metallopeptidase 1a (interstitial collagenase) |
|
multiple interactions |
ISO |
9 |
7,464,141 |
7,476,869 |
RGD:6480464 |
CTD |
| G |
Mmp2 |
matrix metallopeptidase 2 |
|
increases activity |
EXP |
8 |
95,351,227 |
95,377,319 |
RGD:6480464 |
CTD |
| G |
Mmp27 |
matrix metallopeptidase 27 |
|
multiple interactions |
ISO |
9 |
7,571,458 |
7,581,393 |
RGD:6480464 |
CTD |
| G |
Mmp3 |
matrix metallopeptidase 3 |
|
increases expression |
ISO |
9 |
7,445,822 |
7,455,975 |
RGD:6480464 |
CTD |
| G |
Mmp3 |
matrix metallopeptidase 3 |
|
increases secretion |
ISO |
9 |
7,445,822 |
7,455,975 |
RGD:6480464 |
CTD |
| G |
Mmp3 |
matrix metallopeptidase 3 |
|
multiple interactions |
ISO |
9 |
7,445,822 |
7,455,975 |
RGD:6480464 |
CTD |
| G |
Mmp3 |
matrix metallopeptidase 3 |
|
multiple interactions |
ISO |
9 |
7,445,822 |
7,455,975 |
RGD:6480464 |
CTD |
| G |
Mmp7 |
matrix metallopeptidase 7 |
|
multiple interactions |
ISO |
9 |
7,692,111 |
7,699,416 |
RGD:6480464 |
CTD |
| G |
Mmp7 |
matrix metallopeptidase 7 |
|
increases secretion |
ISO |
9 |
7,692,111 |
7,699,416 |
RGD:6480464 |
CTD |
| G |
Mmp7 |
matrix metallopeptidase 7 |
|
increases expression |
EXP |
9 |
7,692,111 |
7,699,416 |
RGD:6480464 |
CTD |
| G |
Mmp7 |
matrix metallopeptidase 7 |
|
multiple interactions |
ISO |
9 |
7,692,111 |
7,699,416 |
RGD:6480464 |
CTD |
| G |
Mmp9 |
matrix metallopeptidase 9 |
|
multiple interactions |
ISO |
2 |
164,773,751 |
164,781,346 |
RGD:6480464 |
CTD |
| G |
Mmp9 |
matrix metallopeptidase 9 |
|
increases activity |
EXP |
2 |
164,773,751 |
164,781,346 |
RGD:6480464 |
CTD |
| G |
Mmp9 |
matrix metallopeptidase 9 |
|
increases expression |
ISO |
2 |
164,773,751 |
164,781,346 |
RGD:6480464 |
CTD |
| G |
Mnd1 |
meiotic nuclear divisions 1 homolog (S. cerevisiae) |
|
increases expression |
ISO |
3 |
83,891,856 |
83,959,708 |
RGD:6480464 |
CTD |
| G |
Mns1 |
meiosis-specific nuclear structural protein 1 |
|
increases expression |
ISO |
9 |
72,286,336 |
72,306,383 |
RGD:6480464 |
CTD |
| G |
Mobp |
myelin-associated oligodendrocytic basic protein |
|
increases expression |
ISO |
9 |
120,058,860 |
120,085,209 |
RGD:6480464 |
CTD |
| G |
Mogat1 |
monoacylglycerol O-acyltransferase 1 |
|
decreases expression |
ISO |
1 |
78,507,635 |
78,534,748 |
RGD:6480464 |
CTD |
| G |
Mphosph9 |
M-phase phosphoprotein 9 |
|
increases expression |
ISO |
5 |
124,700,968 |
124,778,460 |
RGD:6480464 |
CTD |
| G |
Mrpl11 |
mitochondrial ribosomal protein L11 |
|
affects expression |
EXP |
19 |
4,962,306 |
4,966,995 |
RGD:6480464 |
CTD |
| G |
Mrpl12 |
mitochondrial ribosomal protein L12 |
|
affects expression |
EXP |
11 |
120,345,983 |
120,350,068 |
RGD:6480464 |
CTD |
| G |
Mrpl18 |
mitochondrial ribosomal protein L18 |
|
increases expression |
ISO |
17 |
13,104,221 |
13,108,957 |
RGD:6480464 |
CTD |
| G |
Mrpl20 |
mitochondrial ribosomal protein L20 |
|
affects expression |
EXP |
4 |
155,177,727 |
155,182,938 |
RGD:6480464 |
CTD |
| G |
Mrpl52 |
mitochondrial ribosomal protein L52 |
|
affects expression |
EXP |
14 |
55,045,746 |
55,048,587 |
RGD:6480464 |
CTD |
| G |
Mrps18b |
mitochondrial ribosomal protein S18B |
|
affects expression |
EXP |
17 |
36,047,330 |
36,053,314 |
RGD:6480464 |
CTD |
| G |
Msmb |
beta-microseminoprotein |
|
increases expression |
ISO |
14 |
32,955,209 |
32,971,513 |
RGD:6480464 |
CTD |
| G |
Mst1 |
macrophage stimulating 1 (hepatocyte growth factor-like) |
|
increases expression |
ISO |
9 |
107,982,767 |
107,987,358 |
RGD:6480464 |
CTD |
| G |
Mt1 |
metallothionein 1 |
|
increases expression |
ISO |
8 |
96,702,989 |
96,704,227 |
RGD:6480464 |
CTD |
| G |
Mt2 |
metallothionein 2 |
|
increases expression |
ISO |
8 |
96,696,518 |
96,697,467 |
RGD:6480464 |
CTD |
| G |
Mt2 |
metallothionein 2 |
|
multiple interactions |
ISO |
8 |
96,696,518 |
96,697,467 |
RGD:6480464 |
CTD |
| G |
Mt2 |
metallothionein 2 |
|
increases expression |
ISO |
8 |
96,696,518 |
96,697,467 |
RGD:6480464 |
CTD |
| G |
Mt2 |
metallothionein 2 |
|
multiple interactions |
ISO |
8 |
96,696,518 |
96,697,467 |
RGD:6480464 |
CTD |
| G |
Mta3 |
metastasis associated 3 |
|
increases expression |
ISO |
17 |
84,105,503 |
84,214,245 |
RGD:6480464 |
CTD |
| G |
Mthfd1 |
methylenetetrahydrofolate dehydrogenase (NADP+ dependent), methenyltetrahydrofolate cyclohydrolase, formyltetrahydrofolate synthase |
|
decreases expression |
ISO |
12 |
77,356,219 |
77,420,807 |
RGD:6480464 |
CTD |
| G |
Mthfd1l |
methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 1-like |
|
increases expression |
ISO |
10 |
6,179,460 |
6,373,466 |
RGD:6480464 |
CTD |
| G |
Mtor |
mechanistic target of rapamycin (serine/threonine kinase) |
|
increases activity |
ISO |
4 |
147,822,691 |
147,931,794 |
RGD:6480464 |
CTD |
| G |
Mtor |
mechanistic target of rapamycin (serine/threonine kinase) |
|
affects activity |
ISO |
4 |
147,822,691 |
147,931,794 |
RGD:6480464 |
CTD |
| G |
Mtor |
mechanistic target of rapamycin (serine/threonine kinase) |
|
multiple interactions |
ISO |
4 |
147,822,691 |
147,931,794 |
RGD:6480464 |
CTD |
| G |
Myb |
myeloblastosis oncogene |
|
increases expression |
ISO |
10 |
20,844,736 |
20,880,790 |
RGD:6480464 |
CTD |
| G |
Myb |
myeloblastosis oncogene |
|
affects expression |
ISO |
10 |
20,844,736 |
20,880,790 |
RGD:6480464 |
CTD |
| G |
Mybl1 |
myeloblastosis oncogene-like 1 |
|
increases expression |
ISO |
1 |
9,658,912 |
9,690,290 |
RGD:6480464 |
CTD |
| G |
Mybl1 |
myeloblastosis oncogene-like 1 |
|
increases expression |
ISO |
1 |
9,658,912 |
9,690,290 |
RGD:6480464 |
CTD |
| G |
Mybl2 |
myeloblastosis oncogene-like 2 |
|
increases expression |
ISO |
2 |
162,880,371 |
162,910,423 |
RGD:6480464 |
CTD |
| G |
Myc |
myelocytomatosis oncogene |
|
multiple interactions |
ISO |
15 |
61,816,896 |
61,821,916 |
RGD:6480464 |
CTD |
| G |
Myc |
myelocytomatosis oncogene |
|
multiple interactions |
ISO |
15 |
61,816,896 |
61,821,916 |
RGD:6480464 |
CTD |
| G |
Myc |
myelocytomatosis oncogene |
|
affects expression |
ISO |
15 |
61,816,896 |
61,821,916 |
RGD:6480464 |
CTD |
| G |
Myc |
myelocytomatosis oncogene |
|
increases expression |
ISO |
15 |
61,816,896 |
61,821,916 |
RGD:6480464 |
CTD |
| G |
Myc |
myelocytomatosis oncogene |
|
multiple interactions |
ISO |
15 |
61,816,896 |
61,821,916 |
RGD:6480464 |
CTD |
| G |
Myd116 |
myeloid differentiation primary response gene 116 |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Ncoa1 |
nuclear receptor coactivator 1 |
|
decreases expression |
ISO |
12 |
4,247,362 |
4,484,060 |
RGD:6480464 |
CTD |
| G |
Ncoa1 |
nuclear receptor coactivator 1 |
|
increases expression |
ISO |
12 |
4,247,362 |
4,484,060 |
RGD:6480464 |
CTD |
| G |
Ncoa1 |
nuclear receptor coactivator 1 |
|
multiple interactions |
ISO |
12 |
4,247,362 |
4,484,060 |
RGD:6480464 |
CTD |
| G |
Ncoa1 |
nuclear receptor coactivator 1 |
|
affects localization |
EXP |
12 |
4,247,362 |
4,484,060 |
RGD:6480464 |
CTD |
| G |
Ncoa1 |
nuclear receptor coactivator 1 |
|
multiple interactions |
ISO |
12 |
4,247,362 |
4,484,060 |
RGD:6480464 |
CTD |
| G |
Ncoa2 |
nuclear receptor coactivator 2 |
|
multiple interactions |
ISO |
1 |
13,129,240 |
13,364,164 |
RGD:6480464 |
CTD |
| G |
Ncoa2 |
nuclear receptor coactivator 2 |
|
affects binding |
ISO |
1 |
13,129,240 |
13,364,164 |
RGD:6480464 |
CTD |
| G |
Ncoa2 |
nuclear receptor coactivator 2 |
|
multiple interactions |
ISO |
1 |
13,129,240 |
13,364,164 |
RGD:6480464 |
CTD |
| G |
Ncoa2 |
nuclear receptor coactivator 2 |
|
multiple interactions |
ISO |
1 |
13,129,240 |
13,364,164 |
RGD:6480464 |
CTD |
| G |
Ncoa2 |
nuclear receptor coactivator 2 |
|
multiple interactions |
ISO |
1 |
13,129,240 |
13,364,164 |
RGD:6480464 |
CTD |
| G |
Ncoa2 |
nuclear receptor coactivator 2 |
|
multiple interactions |
ISO |
1 |
13,129,240 |
13,364,164 |
RGD:6480464 |
CTD |
| G |
Ncoa2 |
nuclear receptor coactivator 2 |
|
multiple interactions |
ISO |
1 |
13,129,240 |
13,364,164 |
RGD:6480464 |
CTD |
| G |
Ncoa2 |
nuclear receptor coactivator 2 |
|
increases expression |
ISO |
1 |
13,129,240 |
13,364,164 |
RGD:6480464 |
CTD |
| G |
Ncoa2 |
nuclear receptor coactivator 2 |
|
multiple interactions |
ISO |
1 |
13,129,240 |
13,364,164 |
RGD:6480464 |
CTD |
| G |
Ncoa2 |
nuclear receptor coactivator 2 |
|
affects localization |
EXP |
1 |
13,129,240 |
13,364,164 |
RGD:6480464 |
CTD |
| G |
Ncoa3 |
nuclear receptor coactivator 3 |
|
multiple interactions |
ISO |
2 |
165,818,137 |
165,898,742 |
RGD:6480464 |
CTD |
| G |
Ncoa3 |
nuclear receptor coactivator 3 |
|
multiple interactions |
ISO |
2 |
165,818,137 |
165,898,742 |
RGD:6480464 |
CTD |
| G |
Ncoa3 |
nuclear receptor coactivator 3 |
|
multiple interactions |
ISO |
2 |
165,818,137 |
165,898,742 |
RGD:6480464 |
CTD |
| G |
Ncoa3 |
nuclear receptor coactivator 3 |
|
multiple interactions |
ISO |
2 |
165,818,137 |
165,898,742 |
RGD:6480464 |
CTD |
| G |
Ncoa3 |
nuclear receptor coactivator 3 |
|
multiple interactions |
ISO |
2 |
165,818,137 |
165,898,742 |
RGD:6480464 |
CTD |
| G |
Ncoa3 |
nuclear receptor coactivator 3 |
|
multiple interactions |
ISO |
2 |
165,818,137 |
165,898,742 |
RGD:6480464 |
CTD |
| G |
Ncoa3 |
nuclear receptor coactivator 3 |
|
multiple interactions |
ISO |
2 |
165,818,137 |
165,898,742 |
RGD:6480464 |
CTD |
| G |
Ncoa3 |
nuclear receptor coactivator 3 |
|
decreases expression |
ISO |
2 |
165,818,137 |
165,898,742 |
RGD:6480464 |
CTD |
| G |
Ncoa3 |
nuclear receptor coactivator 3 |
|
increases phosphorylation |
ISO |
2 |
165,818,137 |
165,898,742 |
RGD:6480464 |
CTD |
| G |
Ncoa3 |
nuclear receptor coactivator 3 |
|
decreases expression |
ISO |
2 |
165,818,137 |
165,898,742 |
RGD:6480464 |
CTD |
| G |
Ncoa3 |
nuclear receptor coactivator 3 |
|
increases expression |
ISO |
2 |
165,818,137 |
165,898,742 |
RGD:6480464 |
CTD |
| G |
Ncor1 |
nuclear receptor co-repressor 1 |
|
multiple interactions |
ISO |
11 |
62,130,192 |
62,270,834 |
RGD:6480464 |
CTD |
| G |
Ncor1 |
nuclear receptor co-repressor 1 |
|
multiple interactions |
ISO |
11 |
62,130,192 |
62,270,834 |
RGD:6480464 |
CTD |
| G |
Ncor1 |
nuclear receptor co-repressor 1 |
|
multiple interactions |
ISO |
11 |
62,130,192 |
62,270,834 |
RGD:6480464 |
CTD |
| G |
Ncor1 |
nuclear receptor co-repressor 1 |
|
multiple interactions |
ISO |
11 |
62,130,192 |
62,270,834 |
RGD:6480464 |
CTD |
| G |
Ncor1 |
nuclear receptor co-repressor 1 |
|
multiple interactions |
ISO |
11 |
62,130,192 |
62,270,834 |
RGD:6480464 |
CTD |
| G |
Ncor2 |
nuclear receptor co-repressor 2 |
|
multiple interactions |
ISO |
5 |
125,497,525 |
125,659,584 |
RGD:6480464 |
CTD |
| G |
Ncor2 |
nuclear receptor co-repressor 2 |
|
decreases expression |
ISO |
5 |
125,497,525 |
125,659,584 |
RGD:6480464 |
CTD |
| G |
Ncor2 |
nuclear receptor co-repressor 2 |
|
increases expression |
ISO |
5 |
125,497,525 |
125,659,584 |
RGD:6480464 |
CTD |
| G |
Ncor2 |
nuclear receptor co-repressor 2 |
|
multiple interactions |
ISO |
5 |
125,497,525 |
125,659,584 |
RGD:6480464 |
CTD |
| G |
Ncor2 |
nuclear receptor co-repressor 2 |
|
affects expression |
EXP |
5 |
125,497,525 |
125,659,584 |
RGD:6480464 |
CTD |
| G |
Ndc80 |
NDC80 homolog, kinetochore complex component (S. cerevisiae) |
|
increases expression |
ISO |
17 |
71,845,440 |
71,876,197 |
RGD:6480464 |
CTD |
| G |
Ndp |
Norrie disease (pseudoglioma) (human) |
|
multiple interactions |
ISO |
X |
16,462,647 |
16,488,890 |
RGD:6480464 |
CTD |
| G |
Ndrg1 |
N-myc downstream regulated gene 1 |
|
multiple interactions |
ISO |
15 |
66,760,880 |
66,801,203 |
RGD:6480464 |
CTD |
| G |
Ndrg1 |
N-myc downstream regulated gene 1 |
|
increases expression |
ISO |
15 |
66,760,880 |
66,801,203 |
RGD:6480464 |
CTD |
| G |
Ndrg2 |
N-myc downstream regulated gene 2 |
|
decreases expression |
EXP |
14 |
52,524,946 |
52,533,163 |
RGD:6480464 |
CTD |
| G |
Neb |
nebulin |
|
decreases expression |
ISO |
2 |
51,992,167 |
52,194,318 |
RGD:6480464 |
CTD |
| G |
Nedd4l |
neural precursor cell expressed, developmentally down-regulated gene 4-like |
|
affects expression |
EXP |
18 |
65,047,410 |
65,377,480 |
RGD:6480464 |
CTD |
| G |
Nedd4l |
neural precursor cell expressed, developmentally down-regulated gene 4-like |
|
multiple interactions |
ISO |
18 |
65,047,410 |
65,377,480 |
RGD:6480464 |
CTD |
| G |
Nfkbia |
nuclear factor of kappa light polypeptide gene enhancer in B cells inhibitor, alpha |
|
multiple interactions |
ISO |
12 |
56,590,396 |
56,593,634 |
RGD:6480464 |
CTD |
| G |
Nol3 |
nucleolar protein 3 (apoptosis repressor with CARD domain) |
|
affects expression |
ISO |
8 |
107,800,347 |
107,805,839 |
RGD:6480464 |
CTD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
multiple interactions |
EXP |
11 |
78,734,361 |
78,773,626 |
RGD:6480464 |
CTD |
| G |
Nov |
nephroblastoma overexpressed gene |
|
decreases expression |
ISO |
15 |
54,577,483 |
54,585,317 |
RGD:6480464 |
CTD |
| G |
Npy5r |
neuropeptide Y receptor Y5 |
|
multiple interactions |
ISO |
8 |
69,203,864 |
69,211,993 |
RGD:6480464 |
CTD |
| G |
Npy5r |
neuropeptide Y receptor Y5 |
|
increases expression |
ISO |
8 |
69,203,864 |
69,211,993 |
RGD:6480464 |
CTD |
| G |
Nqo1 |
NAD(P)H dehydrogenase, quinone 1 |
|
decreases expression |
ISO |
8 |
109,912,125 |
109,927,105 |
RGD:6480464 |
CTD |
| G |
Nr1h2 |
nuclear receptor subfamily 1, group H, member 2 |
|
decreases expression |
ISO |
7 |
51,805,002 |
51,809,293 |
RGD:6480464 |
CTD |
| G |
Nr1h4 |
nuclear receptor subfamily 1, group H, member 4 |
|
decreases expression |
ISO |
10 |
88,916,979 |
88,996,367 |
RGD:6480464 |
CTD |
| G |
Nr1i2 |
nuclear receptor subfamily 1, group I, member 2 |
|
multiple interactions |
ISO |
16 |
38,248,435 |
38,294,910 |
RGD:6480464 |
CTD |
| G |
Nr1i2 |
nuclear receptor subfamily 1, group I, member 2 |
|
multiple interactions |
ISO |
16 |
38,248,435 |
38,294,910 |
RGD:6480464 |
CTD |
| G |
Nr1i2 |
nuclear receptor subfamily 1, group I, member 2 |
|
increases activity |
ISO |
16 |
38,248,435 |
38,294,910 |
RGD:6480464 |
CTD |
| G |
Nr1i3 |
nuclear receptor subfamily 1, group I, member 3 |
|
increases activity |
EXP |
1 |
173,144,101 |
173,148,975 |
RGD:6480464 |
CTD |
| G |
Nr1i3 |
nuclear receptor subfamily 1, group I, member 3 |
|
increases activity |
EXP |
1 |
173,144,101 |
173,148,975 |
RGD:6480464 |
CTD |
| G |
Nr1i3 |
nuclear receptor subfamily 1, group I, member 3 |
|
increases expression |
EXP |
1 |
173,144,101 |
173,148,975 |
RGD:6480464 |
CTD |
| G |
Nr4a1 |
nuclear receptor subfamily 4, group A, member 1 |
|
decreases expression |
ISO |
15 |
101,097,277 |
101,105,226 |
RGD:6480464 |
CTD |
| G |
Nr4a1 |
nuclear receptor subfamily 4, group A, member 1 |
|
affects expression |
EXP |
15 |
101,097,277 |
101,105,226 |
RGD:6480464 |
CTD |
| G |
Nr4a1 |
nuclear receptor subfamily 4, group A, member 1 |
|
increases expression |
EXP |
15 |
101,097,277 |
101,105,226 |
RGD:6480464 |
CTD |
| G |
Nr4a1 |
nuclear receptor subfamily 4, group A, member 1 |
|
decreases expression |
ISO |
15 |
101,097,277 |
101,105,226 |
RGD:6480464 |
CTD |
| G |
Nr4a2 |
nuclear receptor subfamily 4, group A, member 2 |
|
increases expression |
ISO |
2 |
56,959,637 |
56,976,414 |
RGD:6480464 |
CTD |
| G |
Nr5a1 |
nuclear receptor subfamily 5, group A, member 1 |
|
increases activity |
ISO |
2 |
38,548,180 |
38,570,062 |
RGD:6480464 |
CTD |
| G |
Nr5a1 |
nuclear receptor subfamily 5, group A, member 1 |
|
multiple interactions |
ISO |
2 |
38,548,180 |
38,570,062 |
RGD:6480464 |
CTD |
| G |
Nr5a2 |
nuclear receptor subfamily 5, group A, member 2 |
|
increases expression |
ISO |
1 |
138,740,161 |
138,857,025 |
RGD:6480464 |
CTD |
| G |
Nr5a2 |
nuclear receptor subfamily 5, group A, member 2 |
|
decreases expression |
ISO |
1 |
138,740,161 |
138,857,025 |
RGD:6480464 |
CTD |
| G |
Nrep |
neuronal regeneration related protein |
|
affects expression |
ISO |
18 |
33,596,673 |
33,623,683 |
RGD:6480464 |
CTD |
| G |
Nrf1 |
nuclear respiratory factor 1 |
|
increases expression |
ISO |
6 |
29,997,988 |
30,103,458 |
RGD:6480464 |
CTD |
| G |
Nrf1 |
nuclear respiratory factor 1 |
|
multiple interactions |
ISO |
6 |
29,997,988 |
30,103,458 |
RGD:6480464 |
CTD |
| G |
Nrf1 |
nuclear respiratory factor 1 |
|
multiple interactions |
ISO |
6 |
29,997,988 |
30,103,458 |
RGD:6480464 |
CTD |
| G |
Nrg1 |
neuregulin 1 |
|
decreases expression |
ISO |
8 |
32,928,500 |
33,028,675 |
RGD:6480464 |
CTD |
| G |
Nrip1 |
nuclear receptor interacting protein 1 |
|
affects expression |
ISO |
16 |
76,291,107 |
76,373,294 |
RGD:6480464 |
CTD |
| G |
Nrip1 |
nuclear receptor interacting protein 1 |
|
affects expression |
EXP |
16 |
76,291,107 |
76,373,294 |
RGD:6480464 |
CTD |
| G |
Nrip1 |
nuclear receptor interacting protein 1 |
|
increases expression |
ISO |
16 |
76,291,107 |
76,373,294 |
RGD:6480464 |
CTD |
| G |
Nrip1 |
nuclear receptor interacting protein 1 |
|
multiple interactions |
ISO |
16 |
76,291,107 |
76,373,294 |
RGD:6480464 |
CTD |
| G |
Nrp1 |
neuropilin 1 |
|
increases expression |
EXP |
8 |
130,882,973 |
131,029,376 |
RGD:6480464 |
CTD |
| G |
Nrtn |
neurturin |
|
decreases expression |
ISO |
17 |
56,890,748 |
56,896,953 |
RGD:6480464 |
CTD |
| G |
Nt5c2 |
5'-nucleotidase, cytosolic II |
|
increases expression |
ISO |
19 |
46,961,321 |
47,089,679 |
RGD:6480464 |
CTD |
| G |
Nt5c2 |
5'-nucleotidase, cytosolic II |
|
multiple interactions |
ISO |
19 |
46,961,321 |
47,089,679 |
RGD:6480464 |
CTD |
| G |
Nt5dc2 |
5'-nucleotidase domain containing 2 |
|
increases expression |
ISO |
14 |
31,948,039 |
31,952,310 |
RGD:6480464 |
CTD |
| G |
Ntf3 |
neurotrophin 3 |
|
increases expression |
ISO |
6 |
126,051,430 |
126,116,762 |
RGD:6480464 |
CTD |
| G |
Ntf3 |
neurotrophin 3 |
|
multiple interactions |
ISO |
6 |
126,051,430 |
126,116,762 |
RGD:6480464 |
CTD |
| G |
Nthl1 |
nth (endonuclease III)-like 1 (E.coli) |
|
affects expression |
EXP |
17 |
24,769,627 |
24,775,783 |
RGD:6480464 |
CTD |
| G |
Ntn4 |
netrin 4 |
|
increases expression |
ISO |
10 |
93,103,794 |
93,208,717 |
RGD:6480464 |
CTD |
| G |
Nts |
neurotensin |
|
increases expression |
ISO |
10 |
101,944,390 |
101,953,052 |
RGD:6480464 |
CTD |
| G |
Nudt2 |
nudix (nucleoside diphosphate linked moiety X)-type motif 2 |
|
decreases expression |
ISO |
4 |
41,412,181 |
41,427,959 |
RGD:6480464 |
CTD |
| G |
Nudt6 |
nudix (nucleoside diphosphate linked moiety X)-type motif 6 |
|
multiple interactions |
ISO |
3 |
37,303,906 |
37,318,512 |
RGD:6480464 |
CTD |
| G |
Nuf2 |
NUF2, NDC80 kinetochore complex component, homolog (S. cerevisiae) |
|
increases expression |
ISO |
1 |
171,428,065 |
171,461,595 |
RGD:6480464 |
CTD |
| G |
Nuf2 |
NUF2, NDC80 kinetochore complex component, homolog (S. cerevisiae) |
|
increases expression |
ISO |
1 |
171,428,065 |
171,461,595 |
RGD:6480464 |
CTD |
| G |
Nup133 |
nucleoporin 133 |
|
multiple interactions |
ISO |
8 |
126,421,023 |
126,473,165 |
RGD:6480464 |
CTD |
| G |
Nup133 |
nucleoporin 133 |
|
decreases expression |
ISO |
8 |
126,421,023 |
126,473,165 |
RGD:6480464 |
CTD |
| G |
Nus1 |
nuclear undecaprenyl pyrophosphate synthase 1 homolog (S. cerevisiae) |
|
increases expression |
ISO |
10 |
52,137,353 |
52,159,998 |
RGD:6480464 |
CTD |
| G |
Nusap1 |
nucleolar and spindle associated protein 1 |
|
increases expression |
ISO |
2 |
119,444,034 |
119,475,896 |
RGD:6480464 |
CTD |
| G |
Nxf1 |
nuclear RNA export factor 1 |
|
affects expression |
EXP |
19 |
8,831,593 |
8,845,400 |
RGD:6480464 |
CTD |
| G |
Oas1g |
2'-5' oligoadenylate synthetase 1G |
|
multiple interactions |
ISO |
5 |
121,326,151 |
121,337,607 |
RGD:6480464 |
CTD |
| G |
Oas1g |
2'-5' oligoadenylate synthetase 1G |
|
increases expression |
ISO |
5 |
121,326,151 |
121,337,607 |
RGD:6480464 |
CTD |
| G |
Oas2 |
2'-5' oligoadenylate synthetase 2 |
|
multiple interactions |
ISO |
5 |
121,180,342 |
121,199,857 |
RGD:6480464 |
CTD |
| G |
Oas2 |
2'-5' oligoadenylate synthetase 2 |
|
increases expression |
ISO |
5 |
121,180,342 |
121,199,857 |
RGD:6480464 |
CTD |
| G |
Oas3 |
2'-5' oligoadenylate synthetase 3 |
|
multiple interactions |
ISO |
5 |
121,203,107 |
121,227,668 |
RGD:6480464 |
CTD |
| G |
Oas3 |
2'-5' oligoadenylate synthetase 3 |
|
increases expression |
ISO |
5 |
121,203,107 |
121,227,668 |
RGD:6480464 |
CTD |
| G |
Oasl1 |
2'-5' oligoadenylate synthetase-like 1 |
|
multiple interactions |
ISO |
5 |
115,373,249 |
115,387,920 |
RGD:6480464 |
CTD |
| G |
Oasl1 |
2'-5' oligoadenylate synthetase-like 1 |
|
increases expression |
ISO |
5 |
115,373,249 |
115,387,920 |
RGD:6480464 |
CTD |
| G |
Oip5 |
Opa interacting protein 5 |
|
increases expression |
ISO |
2 |
119,435,268 |
119,444,241 |
RGD:6480464 |
CTD |
| G |
Padi1 |
peptidyl arginine deiminase, type I |
|
increases expression |
EXP |
4 |
140,368,896 |
140,401,693 |
RGD:6480464 |
CTD |
| G |
Pcna |
proliferating cell nuclear antigen |
|
increases expression |
ISO |
2 |
132,075,022 |
132,078,916 |
RGD:6480464 |
CTD |
| G |
Pde3b |
phosphodiesterase 3B, cGMP-inhibited |
|
increases expression |
ISO |
7 |
121,558,768 |
121,681,451 |
RGD:6480464 |
CTD |
| G |
Pde4b |
phosphodiesterase 4B, cAMP specific |
|
affects expression |
ISO |
4 |
101,927,347 |
102,279,867 |
RGD:6480464 |
CTD |
| G |
Pde4c |
phosphodiesterase 4C, cAMP specific |
|
decreases expression |
ISO |
8 |
73,247,963 |
73,275,085 |
RGD:6480464 |
CTD |
| G |
Pde4d |
phosphodiesterase 4D, cAMP specific |
|
decreases methylation |
ISO |
13 |
109,444,371 |
110,741,682 |
RGD:6480464 |
CTD |
| G |
Pde4d |
phosphodiesterase 4D, cAMP specific |
|
increases expression |
ISO |
13 |
109,444,371 |
110,741,682 |
RGD:6480464 |
CTD |
| G |
Pde5a |
phosphodiesterase 5A, cGMP-specific |
|
decreases expression |
ISO |
3 |
122,432,076 |
122,562,292 |
RGD:6480464 |
CTD |
| G |
Pdgfa |
platelet derived growth factor, alpha |
|
multiple interactions |
ISO |
5 |
139,452,925 |
139,470,907 |
RGD:6480464 |
CTD |
| G |
Pdgfa |
platelet derived growth factor, alpha |
|
increases expression |
ISO |
5 |
139,452,925 |
139,470,907 |
RGD:6480464 |
CTD |
| G |
Pdgfa |
platelet derived growth factor, alpha |
|
multiple interactions |
ISO |
5 |
139,452,925 |
139,470,907 |
RGD:6480464 |
CTD |
| G |
Pdgfb |
platelet derived growth factor, B polypeptide |
|
multiple interactions |
ISO |
15 |
79,826,304 |
79,845,238 |
RGD:6480464 |
CTD |
| G |
Pdgfb |
platelet derived growth factor, B polypeptide |
|
multiple interactions |
ISO |
15 |
79,826,304 |
79,845,238 |
RGD:6480464 |
CTD |
| G |
Pdgfra |
platelet derived growth factor receptor, alpha polypeptide |
|
affects expression |
EXP |
5 |
75,548,316 |
75,594,229 |
RGD:6480464 |
CTD |
| G |
Pdk4 |
pyruvate dehydrogenase kinase, isoenzyme 4 |
|
decreases expression |
ISO |
6 |
5,433,351 |
5,446,278 |
RGD:6480464 |
CTD |
| G |
Pdk4 |
pyruvate dehydrogenase kinase, isoenzyme 4 |
|
increases expression |
ISO |
6 |
5,433,351 |
5,446,278 |
RGD:6480464 |
CTD |
| G |
Pdk4 |
pyruvate dehydrogenase kinase, isoenzyme 4 |
|
affects expression |
EXP |
6 |
5,433,351 |
5,446,278 |
RGD:6480464 |
CTD |
| G |
Pdlim3 |
PDZ and LIM domain 3 |
|
affects expression |
ISO |
8 |
46,970,839 |
47,004,900 |
RGD:6480464 |
CTD |
| G |
Pdlim5 |
PDZ and LIM domain 5 |
|
multiple interactions |
ISO |
3 |
141,903,568 |
142,058,630 |
RGD:6480464 |
CTD |
| G |
Pdlim5 |
PDZ and LIM domain 5 |
|
increases expression |
ISO |
3 |
141,903,568 |
142,058,630 |
RGD:6480464 |
CTD |
| G |
Pdpk1 |
3-phosphoinositide dependent protein kinase 1 |
|
multiple interactions |
ISO |
17 |
24,210,647 |
24,278,561 |
RGD:6480464 |
CTD |
| G |
Pds5b |
PDS5, regulator of cohesion maintenance, homolog B (S. cerevisiae) |
|
multiple interactions |
ISO |
5 |
151,476,402 |
151,613,244 |
RGD:6480464 |
CTD |
| G |
Pds5b |
PDS5, regulator of cohesion maintenance, homolog B (S. cerevisiae) |
|
increases expression |
ISO |
5 |
151,476,402 |
151,613,244 |
RGD:6480464 |
CTD |
| G |
Pdzd2 |
PDZ domain containing 2 |
|
multiple interactions |
ISO |
15 |
12,286,809 |
12,522,311 |
RGD:6480464 |
CTD |
| G |
Pdzk1 |
PDZ domain containing 1 |
|
increases expression |
ISO |
3 |
96,633,988 |
96,674,849 |
RGD:6480464 |
CTD |
| G |
Pdzk1 |
PDZ domain containing 1 |
|
affects expression |
ISO |
3 |
96,633,988 |
96,674,849 |
RGD:6480464 |
CTD |
| G |
Pdzk1 |
PDZ domain containing 1 |
|
multiple interactions |
ISO |
3 |
96,633,988 |
96,674,849 |
RGD:6480464 |
CTD |
| G |
Pdzk1 |
PDZ domain containing 1 |
|
increases expression |
ISO |
3 |
96,633,988 |
96,674,849 |
RGD:6480464 |
CTD |
| G |
Peg10 |
paternally expressed 10 |
|
decreases expression |
ISO |
6 |
4,697,306 |
4,710,517 |
RGD:6480464 |
CTD |
| G |
Peli1 |
pellino 1 |
|
multiple interactions |
ISO |
11 |
20,991,327 |
21,050,330 |
RGD:6480464 |
CTD |
| G |
Peli1 |
pellino 1 |
|
increases expression |
ISO |
11 |
20,991,327 |
21,050,330 |
RGD:6480464 |
CTD |
| G |
Peli3 |
pellino 3 |
|
increases expression |
ISO |
19 |
4,931,855 |
4,943,092 |
RGD:6480464 |
CTD |
| G |
Pelo |
pelota homolog (Drosophila) |
|
increases expression |
ISO |
13 |
115,878,563 |
115,880,366 |
RGD:6480464 |
CTD |
| G |
Penk |
preproenkephalin |
|
increases expression |
ISO |
4 |
4,060,683 |
4,065,592 |
RGD:6480464 |
CTD |
| G |
Penk |
preproenkephalin |
|
decreases expression |
EXP |
4 |
4,060,683 |
4,065,592 |
RGD:6480464 |
CTD |
| G |
Penk |
preproenkephalin |
|
increases expression |
ISO |
4 |
4,060,683 |
4,065,592 |
RGD:6480464 |
CTD |
| G |
Penk |
preproenkephalin |
|
multiple interactions |
ISO |
4 |
4,060,683 |
4,065,592 |
RGD:6480464 |
CTD |
| G |
Pepd |
peptidase D |
|
increases expression |
EXP |
7 |
35,697,426 |
35,829,727 |
RGD:6480464 |
CTD |
| G |
Per1 |
period circadian clock 1 |
|
increases expression |
ISO |
11 |
68,912,458 |
68,923,462 |
RGD:6480464 |
CTD |
| G |
Per1 |
period circadian clock 1 |
|
increases expression |
EXP |
11 |
68,912,458 |
68,923,462 |
RGD:6480464 |
CTD |
| G |
Per1 |
period circadian clock 1 |
|
multiple interactions |
ISO |
11 |
68,912,458 |
68,923,462 |
RGD:6480464 |
CTD |
| G |
Pfas |
phosphoribosylformylglycinamidine synthase (FGAR amidotransferase) |
|
multiple interactions |
ISO |
11 |
68,799,203 |
68,821,962 |
RGD:6480464 |
CTD |
| G |
Pfkfb1 |
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 1 |
|
decreases expression |
ISO |
X |
147,024,464 |
147,078,403 |
RGD:6480464 |
CTD |
| G |
Pfkfb3 |
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3 |
|
decreases expression |
ISO |
2 |
11,393,057 |
11,475,556 |
RGD:6480464 |
CTD |
| G |
Pfkfb4 |
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 4 |
|
decreases expression |
ISO |
9 |
108,893,947 |
108,934,739 |
RGD:6480464 |
CTD |
| G |
Pgbd5 |
piggyBac transposable element derived 5 |
|
multiple interactions |
ISO |
8 |
126,892,949 |
126,957,836 |
RGD:6480464 |
CTD |
| G |
Pgf |
placental growth factor |
|
affects expression |
EXP |
12 |
86,507,591 |
86,518,235 |
RGD:6480464 |
CTD |
| G |
Pglyrp1 |
peptidoglycan recognition protein 1 |
|
affects expression |
EXP |
7 |
19,470,039 |
19,475,787 |
RGD:6480464 |
CTD |
| G |
Pglyrp1 |
peptidoglycan recognition protein 1 |
|
increases expression |
EXP |
7 |
19,470,039 |
19,475,787 |
RGD:6480464 |
CTD |
| G |
Pglyrp2 |
peptidoglycan recognition protein 2 |
|
decreases expression |
ISO |
17 |
32,550,045 |
32,557,920 |
RGD:6480464 |
CTD |
| G |
Pgm3 |
phosphoglucomutase 3 |
|
increases expression |
ISO |
9 |
86,446,083 |
86,465,449 |
RGD:6480464 |
CTD |
| G |
Pgr |
progesterone receptor |
|
multiple interactions |
ISO |
9 |
8,899,833 |
8,968,611 |
RGD:6480464 |
CTD |
| G |
Pgr |
progesterone receptor |
|
increases expression |
ISO |
9 |
8,899,833 |
8,968,611 |
RGD:6480464 |
CTD |
| G |
Pgr |
progesterone receptor |
|
increases expression |
ISO |
9 |
8,899,833 |
8,968,611 |
RGD:6480464 |
CTD |
| G |
Pgr |
progesterone receptor |
|
multiple interactions |
ISO |
9 |
8,899,833 |
8,968,611 |
RGD:6480464 |
CTD |
| G |
Pgr |
progesterone receptor |
|
multiple interactions |
ISO |
9 |
8,899,833 |
8,968,611 |
RGD:6480464 |
CTD |
| G |
Pgr |
progesterone receptor |
|
decreases expression |
EXP |
9 |
8,899,833 |
8,968,611 |
RGD:6480464 |
CTD |
| G |
Pgr |
progesterone receptor |
|
increases expression |
EXP |
9 |
8,899,833 |
8,968,611 |
RGD:6480464 |
CTD |
| G |
Pgr |
progesterone receptor |
|
increases expression |
ISO |
9 |
8,899,833 |
8,968,611 |
RGD:6480464 |
CTD |
| G |
Pgr |
progesterone receptor |
|
increases expression |
ISO |
9 |
8,899,833 |
8,968,611 |
RGD:6480464 |
CTD |
| G |
Pgr |
progesterone receptor |
|
increases expression |
ISO |
9 |
8,899,833 |
8,968,611 |
RGD:6480464 |
CTD |
| G |
Pgr |
progesterone receptor |
|
multiple interactions |
ISO |
9 |
8,899,833 |
8,968,611 |
RGD:6480464 |
CTD |
| G |
Pgr |
progesterone receptor |
|
multiple interactions |
ISO |
9 |
8,899,833 |
8,968,611 |
RGD:6480464 |
CTD |
| G |
Pgr |
progesterone receptor |
|
multiple interactions |
ISO |
9 |
8,899,833 |
8,968,611 |
RGD:6480464 |
CTD |
| G |
Pik3r1 |
phosphatidylinositol 3-kinase, regulatory subunit, polypeptide 1 (p85 alpha) |
|
decreases expression |
ISO |
13 |
102,450,716 |
102,538,172 |
RGD:6480464 |
CTD |
| G |
Pim1 |
proviral integration site 1 |
|
affects expression |
ISO |
17 |
29,627,990 |
29,632,410 |
RGD:6480464 |
CTD |
| G |
Plat |
plasminogen activator, tissue |
|
multiple interactions |
ISO |
8 |
23,868,216 |
23,893,320 |
RGD:6480464 |
CTD |
| G |
Plat |
plasminogen activator, tissue |
|
increases secretion |
ISO |
8 |
23,868,216 |
23,893,320 |
RGD:6480464 |
CTD |
| G |
Plk2 |
polo-like kinase 2 |
|
decreases expression |
ISO |
13 |
111,185,252 |
111,191,052 |
RGD:6480464 |
CTD |
| G |
Plk2 |
polo-like kinase 2 |
|
affects expression |
ISO |
13 |
111,185,252 |
111,191,052 |
RGD:6480464 |
CTD |
| G |
Plk2 |
polo-like kinase 2 |
|
affects expression |
EXP |
13 |
111,185,252 |
111,191,052 |
RGD:6480464 |
CTD |
| G |
Plk3 |
polo-like kinase 3 |
|
multiple interactions |
EXP |
4 |
116,801,260 |
116,806,557 |
RGD:6480464 |
CTD |
| G |
Plk4 |
polo-like kinase 4 |
|
increases expression |
ISO |
3 |
40,603,873 |
40,620,805 |
RGD:6480464 |
CTD |
| G |
Plk4 |
polo-like kinase 4 |
|
affects expression |
EXP |
3 |
40,603,873 |
40,620,805 |
RGD:6480464 |
CTD |
| G |
Plod1 |
procollagen-lysine, 2-oxoglutarate 5-dioxygenase 1 |
|
increases expression |
ISO |
4 |
147,283,862 |
147,310,885 |
RGD:6480464 |
CTD |
| G |
Plod2 |
procollagen lysine, 2-oxoglutarate 5-dioxygenase 2 |
|
increases expression |
ISO |
9 |
92,437,061 |
92,503,266 |
RGD:6480464 |
CTD |
| G |
Plod2 |
procollagen lysine, 2-oxoglutarate 5-dioxygenase 2 |
|
affects expression |
ISO |
9 |
92,437,061 |
92,503,266 |
RGD:6480464 |
CTD |
| G |
Plscr1 |
phospholipid scramblase 1 |
|
multiple interactions |
ISO |
9 |
92,145,032 |
92,167,399 |
RGD:6480464 |
CTD |
| G |
Plscr1 |
phospholipid scramblase 1 |
|
increases expression |
ISO |
9 |
92,145,032 |
92,167,399 |
RGD:6480464 |
CTD |
| G |
Pmaip1 |
phorbol-12-myristate-13-acetate-induced protein 1 |
|
increases expression |
ISO |
18 |
66,618,258 |
66,625,212 |
RGD:6480464 |
CTD |
| G |
Pmaip1 |
phorbol-12-myristate-13-acetate-induced protein 1 |
|
affects expression |
ISO |
18 |
66,618,258 |
66,625,212 |
RGD:6480464 |
CTD |
| G |
Pmaip1 |
phorbol-12-myristate-13-acetate-induced protein 1 |
|
increases expression |
ISO |
18 |
66,618,258 |
66,625,212 |
RGD:6480464 |
CTD |
| G |
Pmaip1 |
phorbol-12-myristate-13-acetate-induced protein 1 |
|
multiple interactions |
ISO |
18 |
66,618,258 |
66,625,212 |
RGD:6480464 |
CTD |
| G |
Pmepa1 |
prostate transmembrane protein, androgen induced 1 |
|
decreases expression |
ISO |
2 |
173,049,966 |
173,102,034 |
RGD:6480464 |
CTD |
| G |
Pmp22 |
peripheral myelin protein 22 |
|
multiple interactions |
ISO |
11 |
62,945,012 |
62,973,048 |
RGD:6480464 |
CTD |
| G |
Pmp22 |
peripheral myelin protein 22 |
|
decreases expression |
ISO |
11 |
62,945,012 |
62,973,048 |
RGD:6480464 |
CTD |
| G |
Pnoc |
prepronociceptin |
|
multiple interactions |
ISO |
14 |
66,019,510 |
66,044,046 |
RGD:6480464 |
CTD |
| G |
Pnp |
purine-nucleoside phosphorylase |
|
increases expression |
EXP |
14 |
51,563,978 |
51,573,087 |
RGD:6480464 |
CTD |
| G |
Pnp |
purine-nucleoside phosphorylase |
|
affects expression |
ISO |
14 |
51,563,978 |
51,573,087 |
RGD:6480464 |
CTD |
| G |
Pnpla3 |
patatin-like phospholipase domain containing 3 |
|
decreases expression |
ISO |
15 |
83,998,246 |
84,019,951 |
RGD:6480464 |
CTD |
| G |
Poc5 |
POC5 centriolar protein homolog (Chlamydomonas) |
|
increases expression |
ISO |
13 |
97,158,249 |
97,185,542 |
RGD:6480464 |
CTD |
| G |
Pold4 |
polymerase (DNA-directed), delta 4 |
|
decreases expression |
ISO |
19 |
4,231,899 |
4,233,634 |
RGD:6480464 |
CTD |
| G |
Polr1a |
polymerase (RNA) I polypeptide A |
|
affects expression |
EXP |
6 |
71,859,047 |
71,929,354 |
RGD:6480464 |
CTD |
| G |
Polr2b |
polymerase (RNA) II (DNA directed) polypeptide B |
|
increases expression |
ISO |
5 |
77,739,509 |
77,778,353 |
RGD:6480464 |
CTD |
| G |
Polr2j |
polymerase (RNA) II (DNA directed) polypeptide J |
|
multiple interactions |
ISO |
5 |
136,592,561 |
136,598,817 |
RGD:6480464 |
CTD |
| G |
Polr2l |
polymerase (RNA) II (DNA directed) polypeptide L |
|
affects expression |
EXP |
7 |
148,657,759 |
148,661,052 |
RGD:6480464 |
CTD |
| G |
Pom121 |
nuclear pore membrane protein 121 |
|
affects expression |
EXP |
5 |
135,852,010 |
135,870,416 |
RGD:6480464 |
CTD |
| G |
Pon1 |
paraoxonase 1 |
|
decreases expression |
ISO |
6 |
5,118,090 |
5,143,946 |
RGD:6480464 |
CTD |
| G |
Popdc3 |
popeye domain containing 3 |
|
increases expression |
ISO |
10 |
45,009,111 |
45,038,256 |
RGD:6480464 |
CTD |
| G |
Pou1f1 |
POU domain, class 1, transcription factor 1 |
|
increases expression |
EXP |
16 |
65,520,964 |
65,534,316 |
RGD:6480464 |
CTD |
| G |
Pou5f1 |
POU domain, class 5, transcription factor 1 |
|
multiple interactions |
ISO |
17 |
35,642,984 |
35,647,722 |
RGD:6480464 |
CTD |
| G |
Pou5f1 |
POU domain, class 5, transcription factor 1 |
|
increases expression |
ISO |
17 |
35,642,984 |
35,647,722 |
RGD:6480464 |
CTD |
| G |
Pou5f1 |
POU domain, class 5, transcription factor 1 |
|
multiple interactions |
ISO |
17 |
35,642,984 |
35,647,722 |
RGD:6480464 |
CTD |
| G |
Ppap2b |
phosphatidic acid phosphatase type 2B |
|
multiple interactions |
ISO |
4 |
104,829,952 |
104,905,372 |
RGD:6480464 |
CTD |
| G |
Ppap2b |
phosphatidic acid phosphatase type 2B |
|
decreases expression |
ISO |
4 |
104,829,952 |
104,905,372 |
RGD:6480464 |
CTD |
| G |
Ppap2c |
phosphatidic acid phosphatase type 2C |
|
decreases expression |
ISO |
10 |
78,989,174 |
78,996,532 |
RGD:6480464 |
CTD |
| G |
Ppapdc1b |
phosphatidic acid phosphatase type 2 domain containing 1B |
|
increases expression |
ISO |
8 |
26,830,520 |
26,835,359 |
RGD:6480464 |
CTD |
| G |
Pparg |
peroxisome proliferator activated receptor gamma |
|
multiple interactions |
ISO |
6 |
115,311,239 |
115,440,419 |
RGD:6480464 |
CTD |
| G |
Pparg |
peroxisome proliferator activated receptor gamma |
|
increases expression |
ISO |
6 |
115,311,239 |
115,440,419 |
RGD:6480464 |
CTD |
| G |
Pparg |
peroxisome proliferator activated receptor gamma |
|
decreases expression |
ISO |
6 |
115,311,239 |
115,440,419 |
RGD:6480464 |
CTD |
| G |
Pparg |
peroxisome proliferator activated receptor gamma |
|
increases expression |
EXP |
6 |
115,311,239 |
115,440,419 |
RGD:6480464 |
CTD |
| G |
Ppargc1a |
peroxisome proliferative activated receptor, gamma, coactivator 1 alpha |
|
multiple interactions |
ISO |
5 |
51,845,488 |
51,945,160 |
RGD:6480464 |
CTD |
| G |
Ppargc1b |
peroxisome proliferative activated receptor, gamma, coactivator 1 beta |
|
decreases expression |
ISO |
18 |
61,457,790 |
61,560,085 |
RGD:6480464 |
CTD |
| G |
Ppfibp2 |
PTPRF interacting protein, binding protein 2 (liprin beta 2) |
|
multiple interactions |
ISO |
7 |
114,738,565 |
114,892,097 |
RGD:6480464 |
CTD |
| G |
Ppil6 |
peptidylprolyl isomerase (cyclophilin)-like 6 |
|
increases expression |
ISO |
10 |
41,210,245 |
41,234,094 |
RGD:6480464 |
CTD |
| G |
Ppm1d |
protein phosphatase 1D magnesium-dependent, delta isoform |
|
increases expression |
ISO |
11 |
85,124,756 |
85,160,573 |
RGD:6480464 |
CTD |
| G |
Ppm1e |
protein phosphatase 1E (PP2C domain containing) |
|
multiple interactions |
ISO |
11 |
87,040,408 |
87,172,496 |
RGD:6480464 |
CTD |
| G |
Ppm1e |
protein phosphatase 1E (PP2C domain containing) |
|
increases expression |
ISO |
11 |
87,040,408 |
87,172,496 |
RGD:6480464 |
CTD |
| G |
Ppp1r12a |
protein phosphatase 1, regulatory (inhibitor) subunit 12A |
|
affects expression |
ISO |
10 |
107,599,456 |
107,714,631 |
RGD:6480464 |
CTD |
| G |
Ppp1r14a |
protein phosphatase 1, regulatory (inhibitor) subunit 14A |
|
increases expression |
ISO |
7 |
30,074,339 |
30,078,409 |
RGD:6480464 |
CTD |
| G |
Prim1 |
DNA primase, p49 subunit |
|
increases expression |
ISO |
10 |
127,452,271 |
127,467,086 |
RGD:6480464 |
CTD |
| G |
Prl |
prolactin |
|
multiple interactions |
EXP |
13 |
27,149,439 |
27,157,073 |
RGD:6480464 |
CTD |
| G |
Prl |
prolactin |
|
increases secretion |
EXP |
13 |
27,149,439 |
27,157,073 |
RGD:6480464 |
CTD |
| G |
Prl |
prolactin |
|
increases expression |
ISO |
13 |
27,149,439 |
27,157,073 |
RGD:6480464 |
CTD |
| G |
Prl |
prolactin |
|
increases expression |
ISO |
13 |
27,149,439 |
27,157,073 |
RGD:6480464 |
CTD |
| G |
Prl |
prolactin |
|
increases secretion |
ISO |
13 |
27,149,439 |
27,157,073 |
RGD:6480464 |
CTD |
| G |
Prl |
prolactin |
|
multiple interactions |
ISO |
13 |
27,149,439 |
27,157,073 |
RGD:6480464 |
CTD |
| G |
Prl |
prolactin |
|
increases secretion |
ISO |
13 |
27,149,439 |
27,157,073 |
RGD:6480464 |
CTD |
| G |
Prl |
prolactin |
|
increases expression |
ISO |
13 |
27,149,439 |
27,157,073 |
RGD:6480464 |
CTD |
| G |
Prss23 |
protease, serine, 23 |
|
increases expression |
ISO |
7 |
96,656,295 |
96,666,096 |
RGD:6480464 |
CTD |
| G |
Prss23 |
protease, serine, 23 |
|
multiple interactions |
ISO |
7 |
96,656,295 |
96,666,096 |
RGD:6480464 |
CTD |
| G |
Psat1 |
phosphoserine aminotransferase 1 |
|
increases expression |
ISO |
19 |
15,979,622 |
15,999,515 |
RGD:6480464 |
CTD |
| G |
Psmb9 |
proteasome (prosome, macropain) subunit, beta type 9 (large multifunctional peptidase 2) |
|
increases expression |
ISO |
17 |
34,319,044 |
34,324,275 |
RGD:6480464 |
CTD |
| G |
Psmc5 |
protease (prosome, macropain) 26S subunit, ATPase 5 |
|
affects expression |
EXP |
11 |
106,117,499 |
106,124,426 |
RGD:6480464 |
CTD |
| G |
Psmd12 |
proteasome (prosome, macropain) 26S subunit, non-ATPase, 12 |
|
increases expression |
ISO |
11 |
107,340,842 |
107,359,350 |
RGD:6480464 |
CTD |
| G |
Psmd14 |
proteasome (prosome, macropain) 26S subunit, non-ATPase, 14 |
|
increases expression |
ISO |
2 |
61,549,751 |
61,638,433 |
RGD:6480464 |
CTD |
| G |
Psmd14 |
proteasome (prosome, macropain) 26S subunit, non-ATPase, 14 |
|
affects expression |
EXP |
2 |
61,549,751 |
61,638,433 |
RGD:6480464 |
CTD |
| G |
Psmd4 |
proteasome (prosome, macropain) 26S subunit, non-ATPase, 4 |
|
affects expression |
EXP |
3 |
94,836,627 |
94,846,467 |
RGD:6480464 |
CTD |
| G |
Psmd6 |
proteasome (prosome, macropain) 26S subunit, non-ATPase, 6 |
|
increases expression |
ISO |
14 |
14,944,699 |
14,953,418 |
RGD:6480464 |
CTD |
| G |
Psme4 |
proteasome (prosome, macropain) activator subunit 4 |
|
increases expression |
ISO |
11 |
30,671,775 |
30,780,361 |
RGD:6480464 |
CTD |
| G |
Pspc1 |
paraspeckle protein 1 |
|
affects expression |
EXP |
14 |
57,341,286 |
57,397,153 |
RGD:6480464 |
CTD |
| G |
Ptafr |
platelet-activating factor receptor |
|
affects expression |
ISO |
4 |
132,119,982 |
132,136,781 |
RGD:6480464 |
CTD |
| G |
Ptch1 |
patched homolog 1 |
|
decreases expression |
ISO |
13 |
63,612,841 |
63,666,828 |
RGD:6480464 |
CTD |
| G |
Pten |
phosphatase and tensin homolog |
|
decreases expression |
ISO |
19 |
32,832,067 |
32,900,650 |
RGD:6480464 |
CTD |
| G |
Pten |
phosphatase and tensin homolog |
|
multiple interactions |
ISO |
19 |
32,832,067 |
32,900,650 |
RGD:6480464 |
CTD |
| G |
Pten |
phosphatase and tensin homolog |
|
increases expression |
ISO |
19 |
32,832,067 |
32,900,650 |
RGD:6480464 |
CTD |
| G |
Pten |
phosphatase and tensin homolog |
|
multiple interactions |
ISO |
19 |
32,832,067 |
32,900,650 |
RGD:6480464 |
CTD |
| G |
Pten |
phosphatase and tensin homolog |
|
increases expression |
ISO |
19 |
32,832,067 |
32,900,650 |
RGD:6480464 |
CTD |
| G |
Pten |
phosphatase and tensin homolog |
|
multiple interactions |
ISO |
19 |
32,832,067 |
32,900,650 |
RGD:6480464 |
CTD |
| G |
Pten |
phosphatase and tensin homolog |
|
multiple interactions |
ISO |
19 |
32,832,067 |
32,900,650 |
RGD:6480464 |
CTD |
| G |
Pten |
phosphatase and tensin homolog |
|
decreases expression |
ISO |
19 |
32,832,067 |
32,900,650 |
RGD:6480464 |
CTD |
| G |
Ptger3 |
prostaglandin E receptor 3 (subtype EP3) |
|
affects expression |
ISO |
3 |
157,229,856 |
157,307,722 |
RGD:6480464 |
CTD |
| G |
Ptger3 |
prostaglandin E receptor 3 (subtype EP3) |
|
increases expression |
ISO |
3 |
157,229,856 |
157,307,722 |
RGD:6480464 |
CTD |
| G |
Ptger4 |
prostaglandin E receptor 4 (subtype EP4) |
|
multiple interactions |
ISO |
15 |
5,183,404 |
5,193,831 |
RGD:6480464 |
CTD |
| G |
Ptger4 |
prostaglandin E receptor 4 (subtype EP4) |
|
increases expression |
ISO |
15 |
5,183,404 |
5,193,831 |
RGD:6480464 |
CTD |
| G |
Ptges |
prostaglandin E synthase |
|
multiple interactions |
ISO |
2 |
30,744,991 |
30,758,817 |
RGD:6480464 |
CTD |
| G |
Ptges |
prostaglandin E synthase |
|
increases expression |
ISO |
2 |
30,744,991 |
30,758,817 |
RGD:6480464 |
CTD |
| G |
Ptgfr |
prostaglandin F receptor |
|
affects expression |
EXP |
3 |
151,461,574 |
151,500,492 |
RGD:6480464 |
CTD |
| G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
multiple interactions |
ISO |
1 |
151,947,254 |
151,955,147 |
RGD:6480464 |
CTD |
| G |
Ptk2 |
PTK2 protein tyrosine kinase 2 |
|
increases phosphorylation |
ISO |
15 |
73,035,535 |
73,253,621 |
RGD:6480464 |
CTD |
| G |
Ptpro |
protein tyrosine phosphatase, receptor type, O |
|
decreases expression |
ISO |
6 |
137,200,820 |
137,413,155 |
RGD:6480464 |
CTD |
| G |
Rab30 |
RAB30, member RAS oncogene family |
|
affects expression |
ISO |
7 |
99,890,224 |
99,985,627 |
RGD:6480464 |
CTD |
| G |
Rab31 |
RAB31, member RAS oncogene family |
|
increases expression |
ISO |
17 |
66,001,066 |
66,122,092 |
RGD:6480464 |
CTD |
| G |
Rab32 |
RAB32, member RAS oncogene family |
|
affects expression |
ISO |
10 |
10,264,837 |
10,278,005 |
RGD:6480464 |
CTD |
| G |
Rab5c |
RAB5C, member RAS oncogene family |
|
increases expression |
ISO |
11 |
100,576,580 |
100,599,444 |
RGD:6480464 |
CTD |
| G |
Rad51 |
RAD51 homolog |
|
increases expression |
ISO |
2 |
118,938,553 |
118,961,806 |
RGD:6480464 |
CTD |
| G |
Rad51ap1 |
RAD51 associated protein 1 |
|
increases expression |
ISO |
6 |
126,873,437 |
126,889,573 |
RGD:6480464 |
CTD |
| G |
Rage |
renal tumor antigen |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Ran |
RAN, member RAS oncogene family |
|
affects expression |
ISO |
5 |
129,526,031 |
129,530,196 |
RGD:6480464 |
CTD |
| G |
Rasgrp1 |
RAS guanyl releasing protein 1 |
|
increases expression |
ISO |
2 |
117,105,729 |
117,168,613 |
RGD:6480464 |
CTD |
| G |
Rasl2-9 |
RAS-like, family 2, locus 9 |
|
increases expression |
EXP |
7 |
5,076,544 |
5,077,552 |
RGD:6480464 |
CTD |
| G |
Rbbp8 |
retinoblastoma binding protein 8 |
|
increases expression |
ISO |
18 |
11,816,351 |
11,901,716 |
RGD:6480464 |
CTD |
| G |
Rbm14 |
RNA binding motif protein 14 |
|
decreases expression |
ISO |
19 |
4,800,925 |
4,811,634 |
RGD:6480464 |
CTD |
| G |
Rcor1 |
REST corepressor 1 |
|
decreases expression |
ISO |
12 |
112,278,009 |
112,351,600 |
RGD:6480464 |
CTD |
| G |
Rdh7 |
retinol dehydrogenase 7 |
|
decreases expression |
ISO |
10 |
127,321,083 |
127,326,303 |
RGD:6480464 |
CTD |
| G |
Rela |
v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
|
multiple interactions |
ISO |
19 |
5,637,490 |
5,648,130 |
RGD:6480464 |
CTD |
| G |
Rnd1 |
Rho family GTPase 1 |
|
increases expression |
ISO |
15 |
98,499,636 |
98,507,892 |
RGD:6480464 |
CTD |
| G |
Rora |
RAR-related orphan receptor alpha |
|
multiple interactions |
ISO |
9 |
68,501,609 |
69,226,838 |
RGD:6480464 |
CTD |
| G |
Rora |
RAR-related orphan receptor alpha |
|
increases expression |
ISO |
9 |
68,501,609 |
69,226,838 |
RGD:6480464 |
CTD |
| G |
Rrm2 |
ribonucleotide reductase M2 |
|
increases expression |
ISO |
12 |
25,393,119 |
25,399,011 |
RGD:6480464 |
CTD |
| G |
Ryr2 |
ryanodine receptor 2, cardiac |
|
decreases expression |
ISO |
13 |
11,645,370 |
12,199,212 |
RGD:6480464 |
CTD |
| G |
S100g |
S100 calcium binding protein G |
|
increases expression |
ISO |
X |
159,399,924 |
159,402,531 |
RGD:6480464 |
CTD |
| G |
Saa3 |
serum amyloid A 3 |
|
multiple interactions |
ISO |
7 |
53,967,368 |
53,971,046 |
RGD:6480464 |
CTD |
| G |
Sgk1 |
serum/glucocorticoid regulated kinase 1 |
|
decreases expression |
ISO |
10 |
21,601,990 |
21,719,709 |
RGD:6480464 |
CTD |
| G |
Shcbp1 |
Shc SH2-domain binding protein 1 |
|
increases expression |
ISO |
8 |
4,735,980 |
4,779,534 |
RGD:6480464 |
CTD |
| G |
Slc12a2 |
solute carrier family 12, member 2 |
|
decreases expression |
ISO |
18 |
58,038,332 |
58,106,475 |
RGD:6480464 |
CTD |
| G |
Slc2a2 |
solute carrier family 2 (facilitated glucose transporter), member 2 |
|
decreases expression |
ISO |
3 |
28,596,825 |
28,627,283 |
RGD:6480464 |
CTD |
| G |
Slc30a3 |
solute carrier family 30 (zinc transporter), member 3 |
|
decreases expression |
EXP |
5 |
31,388,479 |
31,395,900 |
RGD:6480464 |
CTD |
| G |
Slc30a3 |
solute carrier family 30 (zinc transporter), member 3 |
|
multiple interactions |
EXP |
5 |
31,388,479 |
31,395,900 |
RGD:6480464 |
CTD |
| G |
Slc6a3 |
solute carrier family 6 (neurotransmitter transporter, dopamine), member 3 |
|
multiple interactions |
ISO |
13 |
73,674,195 |
73,716,120 |
RGD:6480464 |
CTD |
| G |
Slc7a5 |
solute carrier family 7 (cationic amino acid transporter, y+ system), member 5 |
|
increases expression |
ISO |
8 |
124,405,046 |
124,431,586 |
RGD:6480464 |
CTD |
| G |
Spata31d1a |
spermatogenesis associated 31 subfamily D, member 1A |
|
increases expression |
EXP |
13 |
59,801,444 |
59,807,558 |
RGD:6480464 |
CTD |
| G |
Spc24 |
SPC24, NDC80 kinetochore complex component, homolog (S. cerevisiae) |
|
increases expression |
ISO |
9 |
21,559,886 |
21,564,730 |
RGD:6480464 |
CTD |
| G |
Spc25 |
SPC25, NDC80 kinetochore complex component, homolog (S. cerevisiae) |
|
increases expression |
ISO |
2 |
69,031,953 |
69,044,214 |
RGD:6480464 |
CTD |
| G |
Spdl1 |
spindle apparatus coiled-coil protein 1 |
|
increases expression |
ISO |
11 |
34,622,687 |
34,647,143 |
RGD:6480464 |
CTD |
| G |
Star |
steroidogenic acute regulatory protein |
|
decreases expression |
ISO |
8 |
26,918,985 |
26,926,454 |
RGD:6480464 |
CTD |
| G |
Stat3 |
signal transducer and activator of transcription 3 |
|
increases expression |
EXP |
11 |
100,748,124 |
100,800,825 |
RGD:6480464 |
CTD |
| G |
Stc2 |
stanniocalcin 2 |
|
increases expression |
ISO |
11 |
31,259,441 |
31,270,061 |
RGD:6480464 |
CTD |
| G |
Stk39 |
serine/threonine kinase 39 |
|
multiple interactions |
ISO |
2 |
68,048,504 |
68,310,038 |
RGD:6480464 |
CTD |
| G |
Stk39 |
serine/threonine kinase 39 |
|
increases expression |
ISO |
2 |
68,048,504 |
68,310,038 |
RGD:6480464 |
CTD |
| G |
Stmn1 |
stathmin 1 |
|
increases expression |
ISO |
4 |
134,024,235 |
134,029,758 |
RGD:6480464 |
CTD |
| G |
Tacc1 |
transforming, acidic coiled-coil containing protein 1 |
|
decreases expression |
ISO |
8 |
26,265,024 |
26,311,921 |
RGD:6480464 |
CTD |
| G |
Tcf19 |
transcription factor 19 |
|
increases expression |
ISO |
17 |
35,649,680 |
35,653,769 |
RGD:6480464 |
CTD |
| G |
Tert |
telomerase reverse transcriptase |
|
increases activity |
ISO |
13 |
73,764,449 |
73,786,489 |
RGD:6480464 |
CTD |
| G |
Tert |
telomerase reverse transcriptase |
|
increases expression |
ISO |
13 |
73,764,449 |
73,786,489 |
RGD:6480464 |
CTD |
| G |
Tfap2c |
transcription factor AP-2, gamma |
|
affects expression |
ISO |
2 |
172,375,093 |
172,384,122 |
RGD:6480464 |
CTD |
| G |
Tff1 |
trefoil factor 1 |
|
increases expression |
ISO |
17 |
31,298,341 |
31,301,998 |
RGD:6480464 |
CTD |
| G |
Tff1 |
trefoil factor 1 |
|
increases expression |
ISO |
17 |
31,298,341 |
31,301,998 |
RGD:6480464 |
CTD |
| G |
Tff1 |
trefoil factor 1 |
|
multiple interactions |
ISO |
17 |
31,298,341 |
31,301,998 |
RGD:6480464 |
CTD |
| G |
Tff1 |
trefoil factor 1 |
|
multiple interactions |
ISO |
17 |
31,298,341 |
31,301,998 |
RGD:6480464 |
CTD |
| G |
Tff1 |
trefoil factor 1 |
|
multiple interactions |
ISO |
17 |
31,298,341 |
31,301,998 |
RGD:6480464 |
CTD |
| G |
Tff1 |
trefoil factor 1 |
|
multiple interactions |
ISO |
17 |
31,298,341 |
31,301,998 |
RGD:6480464 |
CTD |
| G |
Tff1 |
trefoil factor 1 |
|
increases secretion |
ISO |
17 |
31,298,341 |
31,301,998 |
RGD:6480464 |
CTD |
| G |
Tff1 |
trefoil factor 1 |
|
increases expression |
ISO |
17 |
31,298,341 |
31,301,998 |
RGD:6480464 |
CTD |
| G |
Tff3 |
trefoil factor 3, intestinal |
|
increases expression |
ISO |
17 |
31,262,251 |
31,266,556 |
RGD:6480464 |
CTD |
| G |
Tfpi2 |
tissue factor pathway inhibitor 2 |
|
increases expression |
ISO |
6 |
3,912,595 |
3,918,354 |
RGD:6480464 |
CTD |
| G |
Tgfb1 |
transforming growth factor, beta 1 |
|
affects expression |
ISO |
7 |
26,472,021 |
26,490,015 |
RGD:6480464 |
CTD |
| G |
Tgfbrap1 |
transforming growth factor, beta receptor associated protein 1 |
|
affects expression |
ISO |
1 |
43,104,114 |
43,155,467 |
RGD:6480464 |
CTD |
| G |
Tie1 |
tyrosine kinase with immunoglobulin-like and EGF-like domains 1 |
|
affects expression |
ISO |
4 |
118,143,796 |
118,162,454 |
RGD:6480464 |
CTD |
| G |
Tk1 |
thymidine kinase 1 |
|
increases expression |
ISO |
11 |
117,676,833 |
117,687,328 |
RGD:6480464 |
CTD |
| G |
Tmprss3 |
transmembrane protease, serine 3 |
|
increases expression |
ISO |
17 |
31,316,210 |
31,335,919 |
RGD:6480464 |
CTD |
| G |
Top2a |
topoisomerase (DNA) II alpha |
|
increases expression |
ISO |
11 |
98,854,261 |
98,885,503 |
RGD:6480464 |
CTD |
| G |
Tpm3 |
tropomyosin 3, gamma |
|
increases expression |
ISO |
3 |
89,876,616 |
89,904,526 |
RGD:6480464 |
CTD |
| G |
Ttk |
Ttk protein kinase |
|
increases expression |
ISO |
9 |
83,728,296 |
83,765,997 |
RGD:6480464 |
CTD |
| G |
Ugt2b38 |
UDP glucuronosyltransferase 2 family, polypeptide B38 |
|
multiple interactions |
ISO |
5 |
87,838,964 |
87,853,228 |
RGD:6480464 |
CTD |
| G |
Ugt2b38 |
UDP glucuronosyltransferase 2 family, polypeptide B38 |
|
multiple interactions |
ISO |
5 |
87,838,964 |
87,853,228 |
RGD:6480464 |
CTD |
| G |
Ugt2b38 |
UDP glucuronosyltransferase 2 family, polypeptide B38 |
|
increases expression |
ISO |
5 |
87,838,964 |
87,853,228 |
RGD:6480464 |
CTD |
| G |
Uhrf1 |
ubiquitin-like, containing PHD and RING finger domains, 1 |
|
increases expression |
ISO |
17 |
56,442,760 |
56,462,909 |
RGD:6480464 |
CTD |
| G |
Zswim6 |
zinc finger SWIM-type containing 6 |
|
decreases expression |
ISO |
13 |
108,514,697 |
108,680,258 |
RGD:6480464 |
CTD |
Term paths to the root
|